Ruthenium-diamine complexes and method for producing optically active compounds

ABSTRACT

Provided is a catalyst for asymmetric reduction, which can be produced by a convenient and safe production method, has a strong catalytic activity, and has excellent stereoselectivity. The present invention relates to a ruthenium complex represented by the following formula (1): wherein R 1  represents an alkyl group or the like; Y represents a hydrogen atom; X represents a halogen atom or the like; j and k each represent 0 or 1; R 2  and R 3  each represent an alkyl group or the like; R 11  to R 19  each represent a hydrogen atom, an alkyl group or the like; Z represents oxygen or sulfur; n 1  represents 1 or 2; and n 2  represents an integer from 1 to 3, a method for producing the ruthenium complex, a catalyst for asymmetric reduction formed from the ruthenium complex, and methods for selectively producing an optically active alcohol and an optically active amine using the catalyst for asymmetric reduction.

RELATED APPLICATIONS

This application is the U.S. national phase, pursuant to 35 U.S.C. §371,of PCT international application PCT/JP2011/064490, filed Jun. 17, 2011,designating the United States and published on Mar. 1, 2012 as WO2012/026201 A1, which claims priority to Japanese application2010-189738, filed Aug. 26, 2010. The entire contents of theaforementioned patent applications are incorporated herein by thisreference.

TECHNICAL FIELD

The present invention relates to novel ruthenium-diamine complexes, andmethods for selectively producing an optically active alcohol and anoptically active amine, which are important as precursors for thesyntheses of pharmaceutical products and functional materials, by usingthe complexes as catalysts.

BACKGROUND ART

Numerous asymmetric reactions including asymmetric reduction have beendeveloped, and there have been many reports on asymmetric reactionswhich use an asymmetric metal complex having an optically activephosphine ligand as a catalyst that is used in those asymmetricreactions. On the other hand, it has been frequently reported that, forexample, a complex in which an optically active nitrogen compound iscoordinated to a transition metal such as ruthenium, rhodium or iridium,has excellent performance as a catalyst for asymmetric synthesisreactions. Thus, a wide variety of optically active nitrogen compoundshave been hitherto developed in order to enhance the performance of thiscatalyst (Non-Patent Literatures 1, 2, 3 and 4).

Among others, M. Wills et al. have reported complexes in which a diaminemoiety and an aromatic compound (arene) portion coordinating a rutheniumcomplex are linked via a carbon chain, and these complexes are known toexhibit a higher activity as compared with conventional catalysts(Non-Patent Literatures 5, 6, 7, 8, 9 and 10).

CITATION LIST Non Patent Literature

NPL 1: Chem Rev. (1992) p. 1051

NPL 2: J. Am. Chem. Soc. 117 (1995) p. 7562

NPL 3: J. Am. Chem. Soc. 118 (1996) p. 2521

NPL 4: J. Am. Chem. Soc. 118 (1996) p. 4916

NPL 5: J. Am. Chem. Soc. 127 (2005) p. 7318

NPL 6: J. Org. Chem. 71 (2006) p. 7035

NPL 7: Org. Biomol. Chem. 5 (2007) p. 1093

NPL 8: Org. Lett. 9 (2007) p. 4659

NPL 9: J. Organometallic. Chem. 693 (2008) p. 3527

NPL 10: Dalton. Trans. 39 (2010) p. 1395

SUMMARY OF INVENTION Technical Problem

However, in the conventional methods using these complexes, thecatalytic activity and the enantiomeric excess may be insufficientdepending on the subject reaction or the reaction substrate, anddevelopment of new complexes is desired. Furthermore, even the methodsfor synthesizing those complexes are complicated, or are of low yield,so that many of the methods cause problems in industrial applicationsand the like.

The present invention was made to solve such problems.

Solution to Problem

In order to solve the problems described above, the inventors of thepresent invention paid attention to the chain-like moiety that links thearomatic compound (arene) portion and the diamine moiety that arecoordinated to a ruthenium complex having an optically active diamine,and the inventors found that when the chain-like moiety is constructedas a chain-like moiety having a heteroatom, there is obtained a novelruthenium-diamine complex which has a high catalytic activity and asatisfactory enantiomeric excess, and which can be produced by a simplemethod and is appropriate for industrial use.

That is, the present invention relates to a ruthenium complexrepresented by the formula (1) shown below, a method for producing theruthenium complex, a catalyst for asymmetric reduction formed from theruthenium complex, and methods for selectively producing an opticallyactive alcohol and an optically active amine using the catalyst forasymmetric reduction.

The present invention includes the following matters.

[1] A ruthenium complex represented by the following formula (1):

wherein symbol * represents an asymmetric carbon atom;

R¹ represents an alkyl group having 1 to 10 carbon atoms; a halogenatedalkyl group having 1 to 10 carbon atoms; 10-camphoryl group; an aminogroup which may be substituted with one or two alkyl group having 1 to10 carbon atoms; an aryl group which may be substituted with an alkylgroup having 1 to 10 carbon atoms, a halogenated alkyl group having 1 to10 carbon atoms, a halogen atom, a cyano group (—CN), an amino group, analkylated amino group (—NR²⁰R²¹), a five or six membered cyclic aminogroup, an acylated amino group (—NH—CO—R²⁰), a hydroxyl group, an alkoxygroup (—OR²⁰), an acyl group (—CO—R²⁰), a carboxyl group, analkoxycarbonyl group (—COOR²⁰), a phenoxy carbonyl group, a mercaptogroup, an alkylthio group (—SR²⁰), a silyl group (—SiR²⁰R²¹R²²), or anitro group (—NO₂); R²⁰, R²¹ and R²² each independently represent ahydrogen atom, an alkyl group having 1 to 10 carbon atoms or acycloalkyl group having 3 to 10 carbon atoms;

Y represents a hydrogen atom;

X represents a trifluoromethanesulfonyloxy group, a p-toluenesulfonyloxygroup, a methanesulfonyloxy group, a benzenesulfonyloxy group, ahydrogen atom, or a halogen atom;

j and k each represent 0 or 1, but j+k is not 1;

R² and R³ each independently represent a hydrogen atom; an alkyl grouphaving 1 to 10 carbon atoms; a phenyl group which may be substitutedwith an alkyl group having 1 to 10 carbon atoms, an alkoxy group having1 to 10 carbon atoms, or a halogen atom; or a cycloalkyl group having 3to 8 carbon atoms, or R² and R³ may be joined together to form a ring;

R¹¹, R¹², R¹³, R¹⁴ and R¹⁵ each independently represent a hydrogen atom,an alkyl group having 1 to 10 carbon atoms, or an alkoxy group having 1to 10 carbon atoms;

R¹⁶, R¹⁷, R¹⁸ and R¹⁹ each independently represent a hydrogen atom, ahydroxyl group, an alkyl group having 1 to 10 carbon atoms, or an alkoxygroup having 1 to 10 carbon atoms, or R¹⁶ and R¹⁷ with the carbon atomwhich is substituted with R¹⁶ and R¹⁷, and/or R¹⁸ and R¹⁹ with thecarbon atom which is substituted with R¹⁸ and R¹⁹ may form a carbonylgroup(s);

Z represents an oxygen atom or a sulfur atom; and

n₁ represents 1 or 2, and n₂ represents an integer from 1 to 3.

[2] A ruthenium complex represented by the following formula (2):

wherein symbol * represents an asymmetric carbon atom;

R¹ represents an alkyl group having 1 to 10 carbon atoms; a halogenatedalkyl group having 1 to 10 carbon atoms; 10-camphoryl group; an aminogroup which may be substituted with one or two alkyl group having 1 to10 carbon atoms; an aryl group which may be substituted with an alkylgroup having 1 to 10 carbon atoms, a halogenated alkyl group having 1 to10 carbon atoms, a halogen atom, a cyano group (—CN), an amino group, analkylated amino group (—NR²⁰R²¹), a five or six membered cyclic aminogroup, an acylated amino group (—NH—CO—R²⁰), a hydroxyl group, an alkoxygroup (—OR²⁰), an acyl group (—CO—R²⁰), a carboxyl group, analkoxycarbonyl group (—COOR²⁰), a phenoxy carbonyl group, a mercaptogroup, an alkylthio group (—SR²⁰), a silyl group (—SiR²⁰R²¹R²²), or anitro group (—NO₂); R²⁰, R²¹ and R²² each independently represent ahydrogen atom, an alkyl group having 1 to 10 carbon atoms or acycloalkyl group having 3 to 10 carbon atoms;

Y represents a hydrogen atom;

R² and R³ each independently represent a hydrogen atom; an alkyl grouphaving 1 to 10 carbon atoms; a phenyl group which may be substitutedwith an alkyl group having 1 to 10 carbon atoms, an alkoxy group having1 to 10 carbon atoms, or a halogen atom; or a cycloalkyl group having 3to 8 carbon atoms, or R² and R³ may be joined together to form a ring;

R¹¹, R¹², R¹³, R¹⁴ and R¹⁵ is each independently represent a hydrogenatom, an alkyl group having 1 to 10 carbon atoms, or an alkoxy grouphaving 1 to 10 carbon atoms;

R¹⁶, R¹⁷, R¹⁸ and R¹⁹ each independently represent a hydrogen atom, ahydroxyl group, an alkyl group having 1 to 10 carbon atoms, or an alkoxygroup having 1 to 10 carbon atoms, or R¹⁶ and R¹⁷ with the carbon atomwhich is substituted with R¹⁶ and R¹⁷, and/or R¹⁸ and R¹⁹ with thecarbon atom which is substituted with R¹⁸ and R¹⁹ may form a carbonylgroup(s);

Z represents an oxygen atom or a sulfur atom;

Q represents a counter anion; and

n₁ represents 1 or 2, and n₂ represents an integer from 1 to 3.

[3] A ruthenium complex represented by the following formula (3):

wherein symbol * represents an asymmetric carbon atom;

R¹ represents an alkyl group having 1 to 10 carbon atoms; a halogenatedalkyl group having 1 to 10 carbon atoms; 10-camphoryl group; an aminogroup which may be substituted with one or two alkyl group having 1 to10 carbon atoms; an aryl group which may be substituted with an alkylgroup having 1 to 10 carbon atoms, a halogenated alkyl group having 1 to10 carbon atoms, a halogen atom, a cyano group (—CN), an amino group, anallkylated amino group (—NR²⁰NR²¹), a five or six membered cyclic aminogroup, an acylated amino group (—NH—CO—R²⁰), a hydroxyl group, an alkoxygroup (—OR²⁰), an acyl group (—CO—R²⁰), a carboxyl group, analkoxycarbonyl group (—COOR²⁰), a phenoxy carbonyl group, a mercaptogroup, an alkylthio group (—SR²⁰), a silyl group (—SiR²⁰R²¹R²²), or anitro group (—NO₂); R²⁰, R²¹ and R²² each independently represent ahydrogen atom, an alkyl group having 1 to 10 carbon atoms or acycloalkyl group having 3 to 10 carbon atoms;

Y represents a hydrogen atom;

R² and R³ each independently represent a hydrogen atom; an alkyl grouphaving 1 to 10 carbon atoms; a phenyl group which may be substitutedwith an alkyl group having 1 to 10 carbon atoms, an alkoxy group having1 to 10 carbon atoms, or a halogen atom; or a cycloalkyl group having 3to 8 carbon atoms, or R² and R³ may be joined together to form a ring;

R¹¹, R¹², R¹³, R¹⁴ and R¹⁵ each independently represent a hydrogen atom,an alkyl group having 1 to 10 carbon atoms, or an alkoxy group having 1to 10 carbon atoms;

R¹⁶, R¹⁷, R¹⁸ and R¹⁹ each independently represent a hydrogen atom, ahydroxyl group, an alkyl group having 1 to 10 carbon atoms, or an alkoxygroup having 1 to 10 carbon atoms, or R¹⁶ and R¹⁷ with the carbon atomwhich is substituted with R¹⁶ and R¹⁷, and/or R¹⁸ and R¹⁹ with thecarbon atom which is substituted with R¹⁸ and R¹⁹ may form a carbonylgroup(s);

Z represents an oxygen atom or a sulfur atom;

V represents a halogen atom; and

n₁ represents 1 or 2, and n₂ represents an integer from 1 to 3.

[4] A method for producing a reduction product by reducing an organiccompound in the presence of the ruthenium complex as set forth in anyone of [1] to [3] and a hydrogen donor.

[5] A method for producing an optically active alcohol, the methodcomprising reducing a carbonyl group of a carbonyl compound in thepresence of the ruthenium complex according to any one of [1] to [3] anda hydrogen donor.

[6] A method for producing an optically active amine, the methodcomprising reducing an imino group of an imine compound in the presenceof the ruthenium complex according to any one of [1] to [3] and ahydrogen donor.

[7] The method according to any one of [4] to [6], wherein the hydrogendonor is selected from formic acid, a formic acid alkali metal salt, andan alcohol having a hydrogen atom on the α-position carbon atomsubstituted with a hydroxyl group.

[8] The method according to any one of [4] to [6], wherein the hydrogendonor is hydrogen.

[9] A catalyst for reduction, comprising the ruthenium complex accordingto any one of [1] to [3].

[10] The catalyst for reduction according to [9], wherein the catalystfor reduction is a catalyst for asymmetric reduction.

Advantageous Effects of Invention

The present invention is to provide a novel ruthenium-diamine complexeshaving a heteroatom introduced into the chain-like moiety that links thearomatic compound (arene) portion and the diamine moiety that arecoordinated to ruthenium. The ruthenium-diamine complexes of the presentinvention have highly catalytic activities, can be used for thereduction of the portion of carbonyl group, imino group and ester groupare useful as catalysts for various hydrogenation reactions. Also, thecomplexes of the present invention, in which the ligand is an opticallyactive substance, are excellent in stereoselectivity and give highenantiomeric excess values. Conventional complexes, in which the areneportion and the diamine portion are linked via a carbon chain only, arehighly active; however, the conventional complexes have problems thatthe methods for synthesis of the complexes are complicated; that thesynthesis of the complexes utilizes the Birch reduction, by which theuse of toxic ammonia gas or cryogenic apparatuses is unavoidable; thatthe Swern oxidation must be used, in which the stench odor of dimethylsulfide that is produced as a side product, harmfulness of carbonmonoxide, the necessity of cryogenic apparatuses, and the like cause aproblem in the application of the oxidation process in an industrialscale; and that the complexes give low yield in some of the reactions.However, when a heteroatom is introduced into the chain-like moietyaccording to the present invention, a complex having a side chain thatlinks an arene portion and a diamine portion can be synthesized moreconveniently and efficiently by using an appropriate ruthenium-arenedimer and an appropriate diamine, and by performing a thioetherificationor etherification reaction simultaneously with the formation of thecomplex.

Furthermore, the ruthenium complexes of the present invention having aheteroatom introduced into the chain-like moiety have higher catalyticactivities as compared with the conventional complexes which do not havea heteroatom in the corresponding chain-like moiety, and in which thechain-like moiety is composed of a carbon chain only. When the rutheniumcomplexes of the present invention are used, target substances can beobtained with high optical purity and high yield by a hydrogen transferreaction or a hydrogenation reaction. Particularly, the complexes of thepresent invention in which the ligand is an optically active substanceare useful as catalysts for asymmetric reduction.

When the ruthenium-diamine complexes of the present invention are used,an optically active alcohol or an optically active amine, which are bothuseful as raw materials for pharmaceutical products and functionalmaterials, can be selectively produced.

DESCRIPTION OF EMBODIMENTS

The ruthenium complexes of the present invention represented by theformulas (1), (2), and (3) are ruthenium complexes characterized in thatan aromatic compound (arene) portion is coordinated to a ruthenium atom,and the chain-like moiety which links the aromatic compound (arene)portion and a diamine moiety has a heteroatom such as an oxygen atom ora sulfur atom introduced therein.

Furthermore, the ruthenium complexes represented by the formulas (1) and(2) are characterized in that two nitrogen atoms of a diamine ligand arebonded to a ruthenium atom via covalent bonding or coordination bonding,an aromatic compound (arene) portion that is bonded to the diamine alsohas a tridentate ligand which is coordinated to the ruthenium atom, andthe chain-like moiety that links the aromatic compound (arene) portionand the diamine moiety has a heteroatom such as an oxygen atom or asulfur atom introduced therein.

The symbol * in the formulas (1), (2) and (3) represents that the carbonatom to which the symbol * is attached may optionally become anasymmetric carbon atom. When the carbon atom becomes an asymmetriccarbon atom, the resultant products may be optically active substancesof the ruthenium complexes, may be mixtures of optically activesubstances, or may be racemates (including racemic compounds). In apreferred embodiment of the present invention, when these carbon atomsbecome asymmetric carbon atoms, the resultant products may be opticallyactive substances of the ruthenium complexes.

Furthermore, the ruthenium complexes represented by the formula (2) isruthenium complexes in the case where the Ru—X bond in the rutheniumcomplexes represented by the formula (1) become an ionic bond of Ru⁺-Q⁻.

The ruthenium complex represented by the formula (3) is a dimerinterrupted by a halogen atom V, and is a complex in which an aromaticcompound (arene) portion is coordinated to a ruthenium atom. Theruthenium complex represented by the formula (3) is a ruthenium complexwhich is not only useful as an intermediate in the production of aruthenium complex represented by the formula (1) or (2), but also has anactivity as a reducing catalyst per se.

In regard to the formulas (1), (2), and (3) of the present invention,the alkyl group having 1 to 10 carbon atoms represented by R¹ may be alinear or branched alkyl group having 1 to 10 carbon atoms, andpreferably 1 to 5 carbon atoms. Specific examples of the alkyl groupinclude a methyl group, an ethyl group, an n-propyl group, an isopropylgroup, an n-butyl group, an isobutyl group, an s-butyl group, a t-butylgroup, an n-pentyl group, an n-hexyl group, an n-heptyl group, ann-octyl group, an n-nonyl group, and an n-decyl group.

In regard to the formulas (1), (2), and (3) of the present invention,the halogenated alkyl group having 1 to 10 carbon atoms represented byR¹ is an alkyl group having 1 to 10 carbon atoms, in which a linear orbranched alkyl group described above such as, for example, a methylgroup, an ethyl group, an n-propyl group, an isopropyl group, an n-butylgroup or an n-hexyl group, is substituted with one or more of halogenatoms such as a fluorine atom, a chlorine atom and a bromine atom.Examples the halogenated alkyl group include perfluoroalkyl groups suchas a trifluoromethyl group, a pentafluoromethyl group, and aheptafluoropropyl group.

In regard to the formulas (1), (2), and (3) of the present invention,the aryl group of the aryl group which is optionally substituted with analkyl group having 1 to 10 carbon atoms, a halogenated alkyl grouphaving 1 to 10 carbon atoms, a halogen atom, a cyano group (—CN), anamino group, an alkylated amino group (—NR²⁰R²¹), a five or six memberedcyclic amino group, an acylated amino group (—NH—CO—R²⁰), a hydroxylgroup, an alkoxy group (—OR²⁰), an acyl group (—CO—R²⁰), a carboxylgroup, an alkoxycarbonyl group (—COOR²⁰), a phenoxy carbonyl group, amercapto group, an alkylthio group (—SR²⁰), a silyl group(—SiR²⁰R²¹R²²), or a nitro group (—NO₂), as represented by R¹, may be amonocyclic, polycyclic or fused-ring aryl group having 1 to 20 carbonatoms, and preferably 6 to 12 carbon atoms, such as a phenyl group or anaphthyl group. The alkyl group having 1 to 10 carbon atoms may be thesame alkyl group as defined above. The halogenated alkyl group having 1to 10 carbon atoms may be the same halogenated alkyl group as definedabove, for example, a perfluoroakyl group. The halogen atom may be afluorine atom, a chlorine atom or the like.

The alkylated amino group is represented by the formula —NR²⁰R²¹,wherein R²⁰ and R²¹ each independently represent a hydrogen atom, analkyl group having 1 to 10 carbon atoms or cycloalkyl group having 3 to10 carbon atoms. Examples of the alkylated amino group, include mono- ordi-alkylamino groups such as N-methylamino, N,N-dimethylamino,N,N-diethylamino, N,N-diisopropylamino or N-cyclohexylamino groups, orthe like.

The five- or six-membered cyclic amino group is a 5 or 6-memberedsaturated or unsaturated heterocyclic group having one or two basicnitrogen atoms. Examples of the five- or six-membered cyclic amino groupinclude a pyrrolidino group, piperidino group or a morpholino group, orthe like.

The acyl group is represented by the formula —CO—R²⁰, wherein R²⁰represent a hydrogen atom, an alkyl group having 1 to 10 carbon atoms orcycloalkyl group having 3 to 10 carbon atoms. Examples of the acylgroup, include formyl, acetyl, propionyl, butyryl, pivaloyl, pentanoylor hexanoyl, or the like.

The acylated amino group is represented by the formula —NH—CO—R²⁰,wherein R²⁰ represent a hydrogen atom, an alkyl group having 1 to 10carbon atoms or cycloalkyl group having 3 to 10 carbon atoms. Examplesof the acylated amino group, include formylamino, acetylamino,propionylamino, pivaloylamino, pentanoylamino or hexanoylamino, or thelike.

The alkoxy group is represented by the formula —OR²⁰, wherein R²⁰represent a hydrogen atom, an alkyl group having 1 to 10 carbon atoms orcycloalkyl group having 3 to 10 carbon atoms, for example, methoxy,ethoxy, n-propoxy, isopropoxy, n-butoxy, s-butoxy, isobutoxy, t-butoxy,n-pentyloxy, 2-methylbutoxy, 3-methylbutoxy, 2,2-dimethylpropyloxy,n-hexyloxy, 2-methylpentyloxy, 3-methylpentyloxy, 4-methylpentyloxy,5-methylpentyloxy or cyclohexyloxy groups, or the like.

The alkoxycarbonyl group is represented by the formula —COOR²⁰, whereinR²⁰ represent a hydrogen atom, an alkyl group having 1 to 10 carbonatoms or cycloalkyl group having 3 to 10 carbon atoms, for example,methoxycarbonyl, ethoxycarbonyl, n-propoxycarbonyl, isopropoxycarbonyl,n-butoxycarbonyl, t-butoxycarbonyl, pentyloxycarbonyl, hexyloxycarbonylor 2-ethylhexyloxycarbonyl, or the like.

The alkylthio group is represented by the formula —SR²⁰, wherein R²⁰represent a hydrogen atom, an alkyl group having 1 to 10 carbon atoms orcycloalkyl group having 3 to 10 carbon atoms, for example, methylthio,ethylthio, n-propylthio, isopropylthio, n-butylthio, s-butylthio,isobutylthio, t-butylthio, pentylthio, hexylthio or cyclohexylthiogroups, or the like.

The silyl group is represented by the formula —SiR²⁰R²¹R²², wherein R²⁰,R²¹ and R²² each independently represent a hydrogen atom, an alkyl grouphaving 1 to 10 carbon atoms or cycloalkyl group having 3 to 10 carbonatoms, for example, trimethylsilyl, triisopropylsilyl,t-butyldimethylsilyl, t-butyldiphenylsilyl or triphenylsilyl groups, orthe like.

The cycloalkyl group having 3 to 10 carbon atoms is a monocyclic,polycyclic or fused-ring, and saturated or unsaturated 3 to 7-memberedcycloalkyl group having 3 to 10 carbon atoms.

Examples of such an aryl group include a phenyl group, an o-, m- orp-tolyl group, an o-, m- or p-ethylphenyl group, an o-, m- orp-isopropylphenyl group, an o-, m- or p-t-butylphenyl group, a2,4,6-trimethylphenyl group, a 3,5-xylyl group, a2,4,6-triisopropylphenyl group, an o-, m- or p-trifluoromethylphenylgroup, an o-, m- or p-fluorophenyl group, an o-, m- or p-chlorophenylgroup, and a pentafluorophenyl group.

In regard to the formulas (1), (2), and (3) of the present invention,the alkyl group having 1 to 10 carbon atoms represented by R² and R³ maybe a linear or branched alkyl group having 1 to 10 carbon atoms, andpreferably 1 to 5 carbon atoms. Specific examples of the alkyl groupinclude a methyl group, an ethyl group, an n-propyl group, an isopropylgroup, an n-butyl group, an isobutyl group, an s-butyl group, a t-butylgroup, an n-pentyl group, an n-hexyl group, an n-heptyl group, ann-octyl group, an n-nonyl group, and an n-decyl group.

In regard to the formulas (1), (2), and (3) of the present invention,the alkyl group of the phenyl group which may be substituted with analkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10carbon atoms, or a halogen atom, as represented by R² and R³, may be,for example, the same alkyl group as defined above. Examples of thehalogen atom include a fluorine atom, a chlorine atom, and a bromineatom.

The alkoxy group having 1 to 10 carbon atoms may be a linear or branchedalkoxy group having 1 to 10 carbon atoms, and preferably 1 to 5 carbonatoms. Specific examples of the alkoxy group include a methoxy group, anethoxy group, an n-propoxy group, an isopropoxy group, an n-butoxygroup, an isobutoxy group, an s-butoxy group, a t-butoxy group, ann-pentyloxy group, an n-hexyloxy group, an n-heptyloxy group, ann-octyloxy group, an n-nonyloxy group, and an n-decyloxy group.

In regard to the formulas (1), (2), and (3) of the present invention,the cycloalkyl group having 3 to 8 carbon atoms as represented by R² andR³ may be a monocyclic, polycyclic or bridged cycloalkyl group having 3to 8 carbon atoms, and preferably 5 to 8 carbon atoms. Specific examplesof the cycloalkyl group include a cyclopropyl group, a cyclobutyl group,a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, and acyclooctyl group. These cycloalkyl groups may be substituted with analkyl group such as a methyl group, an isopropyl group or a t-butylgroup, or the like.

Furthermore, when R² and R³ are joined together to form a ring, R² andR³ are joined to form a linear or branched alkylene group having 2 to 10carbon atoms, and preferably 3 to 10 carbon atoms, and the resultingalkylene group forms, together with adjacent carbon atoms, a 4- to8-membered, and preferably 5- to 8-membered, cycloalkane ring. Preferredexamples of the cycloalkane ring include a cyclopentane ring, acyclohexane ring, and a cycloheptane ring, and these rings may each havean alkyl group such as a methyl group, an isopropyl group or a t-butylgroup as a substituent.

In regard to the arene moiety represented by the formulas (1), (2), and(3) of the present invention, R¹¹, R¹², R¹³, R¹⁴ and R¹⁵ eachindependently represent a hydrogen atom, an alkyl group having 1 to 10carbon atoms, or an alkoxy group having 1 to 10 carbon atoms. The alkylgroup may be the same alkyl group as defined above, and specificexamples of the alkyl group include a methyl group, an ethyl group, ann-propyl group, an isopropyl group, an n-butyl group, an isobutyl group,an s-butyl group, a t-butyl group, an n-pentyl group, an n-hexyl group,an n-heptyl group, an n-octyl group, an n-nonyl group, and an n-decylgroup.

The alkoxy group may be the same linear or branched alkoxy group asdefined above, and specific examples of the alkoxy group include amethoxy group, an ethoxy group, an n-propoxy group, an isopropoxy group,an n-butoxy group, an isobutoxy group, an s-butoxy group, a t-butoxygroup, an n-pentyloxy group, an n-hexyloxy group, an n-heptyloxy group,an n-octyloxy group, an n-nonyloxy group, and an n-decyloxy group.

R¹⁶, R¹⁷, R¹⁸ and R¹⁹ representing the substituents substituted on thecarbon atoms of the chain-like moiety that links the arene portion andthe diamine moiety represented by the formulas (1), (2), and (3), eachindependently represent a hydrogen atom, a hydroxyl group, an alkylgroup having 1 to 10 carbon atoms, or an alkoxy group having 1 to 10carbon atoms. The alkyl group may be the same alkyl group as definedabove, and specific examples thereof include a methyl group, an ethylgroup, an n-propyl group, an isopropyl group, an n-butyl group, anisobutyl group, an s-butyl group, a t-butyl group, an n-pentyl group, ann-hexyl group, an n-heptyl group, an n-octyl group, an n-nonyl group,and an n-decyl group.

The alkoxy group may be the same linear or branched alkoxy group asdefined above, and specific examples of the alkoxy group include amethoxy group, an ethoxy group, an n-propoxy group, an isopropoxy group,an n-butoxy group, an isobutoxy group, an s-butoxy group, a t-butoxygroup, an n-pentyloxy group, an n-hexyloxy group, an n-heptyloxy group,an n-octyloxy group, an n-nonyloxy group, and an n-decyloxy group.

Preferred examples of the —(—C(R¹⁶)R¹⁷—)n₁-group include a —CH₂— group,a —CH(CH₃)— group, and a —CO— group, but the —(—C(R¹⁶)R¹⁷—)n₁-group isnot intended to be limited to these.

Z in the formulas (1), (2), and (3) represents an oxygen atom (—O—) or asulfur atom (—S—).

k and j in the formula (1) each represent an integer of 0 or 1, and thesum j+k is not equal to 1. That is, when k is 1, j is also 1, and when kis 0, j is also 0. When k is 1, Y represents a hydrogen atom.

When j in the formula (1) is 1, X may be a hydrogen atom or a halogenatom, but X is preferably a halogen atom. Specifically, a preferredexample of X is a chlorine atom.

The hydrogen atom of Y in the formulas (1), (2) and (3) and of X in theformula (1) may be an ordinary hydrogen atom, and may also be an isotopeof a hydrogen atom. A preferred example of the isotope is a deuteriumatom.

Q^(⊖) in the formula (2) represents a counter anion. Specific examplesof the counter anion include alkyl- or arenesulfonyloxy ions such as atrifluoromethanesulfonyloxy ion (TfO⁻), a p-toluenesulfonyloxy ion(TsO⁻), a methanesulfonyloxy ion (MsO⁻), and a benzenesulfonyloxy ion(BsO⁻); and ions such as BF₄ ⁻, SbF₆ ⁻, CF₃COO⁻, CH₃COO⁻, PF₆ ⁻, NO₃ ⁻,ClO₄ ⁻, SCN⁻, OCN⁻, ReO₄ ⁻, MoO₄ ⁻, BPh₄ ⁻, B(C₆F₅)₄ ⁻, andB(3,5-(CF₃)₂C₆F₃)₄ ⁻.

The halogen atom represented by V in the formula (3) represents achlorine atom, a bromine atom or an iodine atom, and all V's mayrepresent an identical halogen atom, or may represent a combination ofdifferent halogen atoms.

The complex of the present invention can be synthesized by, for example,the method of the following Scheme (1).

In the Scheme (1), R¹, R², R³, R¹¹ to R¹⁵, and R¹⁶ to R¹⁹ respectivelyrepresent the same substituents as defined above; Y represents ahydrogen atom or a deuterium atom; and Z represents an oxygen atom or asulfur atom. W in the ruthenium-arene dimer (a) represents a halogenatom, or an alkanesulfonyloxy or optionally substituted arenesulfonyloxygroup; and V represents a halogen atom. n₁ represents an integer of 1 or2, and n₂ represents an integer from 1 to 3.

As shown in the Scheme (1), when a ruthenium-arene dimer (a) having ahalogen atom or the like at a terminal of the substituent of the arene,is reacted with a diamine (b) having a hydroxyl group or a thiol groupat a terminal of the chain-like portion substituted with a nitrogen atomthat is other than the nitrogen atom substituted with a sulfonyl group,in the presence of an appropriate base, and thereby a thioetherificationor etherification reaction is carried out simultaneously withcomplexation, a ruthenium-diamine complex (d), which is the targetcomplex, can be synthesized directly or via an amido complex (c) as anintermediate. When the amide complex (c) is employed as an intermediate,the amido complex can be converted to a diamine complex (d) or acationic diamine complex (g) by adding an appropriate acid to thecomplex (c).

Examples of the halogen atom or the alkanesulfonyloxy or optionallysubstituted arenesulfonyloxy group, which is represented by W in theruthenium-arene dimer (a), include a chlorine atom, a bromine atom, aniodine atom, a methanesulfonyloxy group, a p-toluenesulfonyloxy group, abenzenesulfonyloxy group, and a trifluoromethanesulfonyloxy group.Furthermore, the halogen atom represented by V may be a chlorine atom, abromine atom or an iodine atom, and all V's may represent an identicalhalogen atom, or may represent a combination of different halogen atoms.

Z in the diamine (b) represents an oxygen atom or a sulfur atom.Furthermore, Y represents a hydrogen atom.

Examples of the base that is used in case of synthesizing the amidocomplex (c) include inorganic bases such as LiOH, NaOH, KOH, K₂CO₃, andCs₂CO₃; and metal alkoxides such as sodium methoxide and potassiummethoxide. The amount of addition of the base is 2 moles or morerelative to the amount of ruthenium atoms. There are no particularlimitations on the solvent used in this case, but ethers such as diethylether and tetrahydrofuran; aromatic hydrocarbons such as toluene andxylene; halogen-containing hydrocarbon solvents such as dichloromethaneand 1,2-dichloroethane; aprotic polar solvents such as acetonitrile andN,N-dimethylformamido; and the like are preferred, while dichloromethaneand toluene are particularly preferred. Furthermore, this reaction canbe carried out as a two-layer system reaction by using water as anothersolvent in addition to an organic solvent. In this case, the reactionmay be carried out using a phase transfer catalyst. Examples of thephase transfer catalyst used in this case include tetrabutylammoniumchloride, tetrabutylammonium bromide, tetrabutylammonium iodide,tetraethylammonium chloride, tetraethylammonium bromide,tetraethylammonium iodide, triethylbenzylammonium chloride,triethylbenzylammonium bromide, and triethylbenzylammonium iodide.

Examples of the acid (X—Y) used when the amido complex (c) is convertedto a diamine complex (d) include hydrochloric acid, hydrobromic acid,and hydriodic acid.

Similarly, the amido complex (c) can also be converted to a cationicdiamine complex (g). Examples of the acid (Q-H) used in this caseinclude trifluoromethanesulfonic acid (TfOH), methanesulfonic acid(MsOH), p-toluenesulfonic acid (TsOH), benzenesulfonic acid (BsOH),HBF₄, HSbF₆, CF₃COOH, CH₃COOH, HPF₆, HNO₃, HClO₄, HSCN, HOCN, HReO₄, andHMoO₄.

There are no particular limitations on the solvent used to carry outthis reaction; however, after the synthesis of the amido complex (c)described above, the amido complex (c) may be directly subjected to areaction, without isolating the complex, in the presence of the samesolvent within the system to be converted to the diamine complex (d) or(g), or alternatively, the amido complex (c) may be isolated and thensubjected to a reaction using an appropriate, different solvent to beconverted to the diamine complex (d) or the cationic diamine complex(g).

As the base used in the case of directly synthesizing the diaminecomplex (d), organic tertiary amines such as trimethylamine,triethylamine, triisopropylamine, and diisopropylethylamine arepreferred, and particularly, triethylamine and diisopropylethylamine aresuitable. The amount of addition of the base in this case is equimolaror greater relative to the amount of the ruthenium atoms.

There are no particular limitations on the solvent used in this case,but ethers such as diethyl ether and tetrahydrofuran; alcohols such asmethanol, ethanol and isopropanol; aromatic hydrocarbons such as tolueneand xylene; halogenic solvents such as dichloromethane and1,2-dichloroehtane; aprotic polar solvents such as acetonitrile andN,N-dimethylformamide; and the like are preferred, while dichloromethaneand isopropanol are particularly preferred.

Furthermore, as a method for synthesizing the complex of the presentinvention, a ruthenium-arene dimer (e) having a hydroxyl group or athiol group at a terminal of the substituent of the arene, and a diamine(f) having a halogen atom or the like at a terminal of the chain-likeportion substituted at a nitrogen atom that is other than the nitrogenatom substituted with a sulfonyl group, can also be used as rawmaterials, as shown in the following Scheme (2).

(The respective symbols in Scheme (2) have the same meanings as definedin Scheme (1)).

In the Scheme (2), the positions of the hydroxyl group or thiol groupand the leaving group such as a halogen atom are the reverse of thecombination used in the Scheme (1). However, the ruthenium-diaminecomplex (d) or the cationic diamine complex (g), which are both targetcomplexes, can be similarly synthesized directly or via the amidocomplex (c), by allowing the hydroxyl group or thiol group and theleaving group to react in the presence of an appropriate base, andperforming a thioetherification or etherification reactionsimultaneously with complexation. When the amido complex (c) is employedas an intermediate, the amido complex can be converted to a diaminecomplex (d) or a cationic diamine complex (g) by adding an appropriateacid to the complex (c). The base, solvent and the like used in thereaction respectively have the same meanings as defined above.

Furthermore, the complex of the present invention can also be producedby a method such as shown in the following Scheme (3).

(I) A compound (h) having a 1,4-cyclohexadiene skeleton is synthesizedby using the Diels-Alder reaction.

(II) The compound (h) obtained in the item (1) is subjected totosylation or the like, and thereby a compound (i) having a leavinggroup at a terminal is synthesized.

(III) The compound (i) is made to react with TsDPEN(N-(p-toluensulfonyl)-1,2-diphenylethylenediamine), and thereby adiamine (j) having cyclohexadiene is synthesized.

(IV) The diamine (j) thus obtained is made to react with rutheniumtrichloride to obtain a ruthenium dimer (k) as an intermediate, andthereby the target monomer complex is obtained.

Through this method, the ruthenium complex represented by the formula(1) and (3) of the present invention can be produced.

Furthermore, the ruthenium complexes represented by the formula (2) ofthe present invention can also be produced by a method such as shown inthe following Scheme (4).

As shown in the Scheme (4), the cationic diamine complex (g) can also beobtained by allowing a diamine complex (d) in which X is a halogen atom,to react with a metal salt represented by the formula M-Q. Examples ofthe metal M in the formula: M-Q include silver (Ag), sodium (Na),potassium (K), and lithium (Li). Examples of the moiety Q includealkanesulfonyloxy or arenesulfonyloxy compounds such astrifluoromethanesulfonyloxy (TfO), p-toluenesulfonyloxy (TsO),methanesulfonyloxy (MsO), and benzenesulfonyloxy (BsO); as well as BF₄,SbF₆, CF₃COO, CH₃COO, PF₆, NO₃, ClO₄, SCN, OCN, ReO₄, MoO₄, BPh₄,B(C₆F₅)₄, and B(3,5-(CF₃)₂C₆F₃)₄.

Examples of the metal salt represented by the formula: M-Q includeAgOTf, AgOTs, AgOMs, AgOBs, AgBF₄, AgSbF₆, CF₃COOAg, CH₃COOAg, AgPF₆,AgNO₃, AgClO₄, AgSCN, AgOCN, AgReO₄, AgMoO₄, NaOTf, NaBF₄, NaSbF₆,CF₃COONa, CH₃COONa, NaPF₆, NaNO₃, NaClO₄, NaSCN, KOTf, KBF₄, KSbF₆,CF₃COOK, CH₃COOK, KPF₆, KNO₃, KClO₄, KSCN, KBPh₄, KB(C₆F₅)₄,KB(3,5-(CF₃)₂C₆F₃)₄, LiOTf, LiBF₄, LiSbF₆, CF₃COOLi, CH₃COOLi, LiPF₆,LNO₃, LiClO₄, LiSCN, LiBPh₄, LiB(C₆F₅)₄, and LiB(3,5-(CF₃)₂C₆F₃)₄.

The amount of the metal salt M-Q that is used in the case ofsynthesizing the cationic diamine complex (g) is equimolar or greaterrelative to the amount of ruthenium atoms. There are no particularlimitations on the solvent used in this case, but examples of thesolvent include alcohols such as methanol, ethanol, and isopropanol;aromatic hydrocarbons such as toluene and xylene; halogenatedhydrocarbons such as dichloromethane and 1,2-dichloroethane; aproticpolar solvents such as acetonitrile and N,N-dimethylformamido; andethers such as diethyl ether and tetrahydrofuran. Among these, methanolis preferred.

As such, the ruthenium complex of the present invention having aheteroatom introduced into the chain-like moiety can be synthesizedusing an appropriate ruthenium-arene dimer and an appropriate diamine,by carrying out a thioetherification or etherification reactionsimultaneously with the formation of the complex, and thereby a complexhaving a side chain that links the arene portion and the diamine portioncan be synthesized. Theoretically, in this reaction, the complex can beproduced by allowing the ruthenium-arene dimer to react in an equimolaramount, in terms of ruthenium, based on the diamine, and therefore, thereaction is very efficient. Also, since the reactions used in thissynthesis method are all reaction that are carried out under theconditions ranging from normal temperature to a heating condition, it isnot necessary to use cryogenic apparatuses, and harmful gases and thelike are not generated. Thus, this method is a synthesis method which isvery simple, safe and expedient when synthesis is carried out in anindustrial scale.

The ruthenium complex of the present invention in which X is a halogenatom can be readily converted to a complex in which X is a hydrogen atomby bringing the ruthenium complex into contact with a hydrogen donor.

Here, as the hydrogen donor, those generally used as hydrogen donors inhydrogen transfer type reduction reactions of a metal hydride such as aborohydride compound, formic acid or a salt thereof, isopropanol and thelike, can be used. The amount of use of the hydrogen donor may be anequimolar amount or greater, in terms of hydride, relative to the amountof the catalyst. Furthermore, hydrogen gas can also be used as ahydrogen donor.

Furthermore, examples of the base that is used to obtain basicconditions include organic tertiary amines such as trimethylamine,triethylamine, and triisopropylamine; inorganic bases such as LiOH,NaOH, KOH, and K₂CO₃; and metal alkoxides such as sodium methoxide, andpotassium methoxide.

Furthermore, conversion of a halogen atom to a hydrogen atom for X inthe ruthenium complex of the present invention may be carried out inadvance before the reaction system is subjected to the asymmetricreduction reaction, or may also be carried out in the middle of theasymmetric reduction reaction.

The production of the ruthenium complex of the present invention isusually carried out at 120° C. or below, and preferably at 100° C. orbelow.

The asymmetric reduction reaction may be carried out by using a compoundobtained by isolating the amido complex (c), the diamine complex (d),the cationic diamine complex (g), or the ruthenium dimer(k) as acatalyst, or may also be carried out without isolating the complex, bydirectly using the reaction liquid resulting from the production of acomplex (in situ method).

After completion of the reaction, the intended ruthenium complex can beseparated by a general precipitation technique such as concentration ofthe reaction liquid or addition of a poor solvent. Furthermore, if ahydrogen halide salt is produced as a side product during the productiondescribed above, an operation of water washing may be performed asnecessary.

The asymmetric reduction reaction of the present invention is carriedout by allowing a ruthenium complex represented by the formula (1) toreact with a carbonyl compound or an imine in the co-presence of ahydrogen donor. There are no particular limitations on the hydrogendonor, as long as it is a hydrogen donor that is generally used inhydrogen transfer reduction reactions of formic acid or a salt thereof,isopropanol which is an alcohol having a hydrogen atom on the α-positioncarbon atom substituted with a hydroxyl group, and the like.Furthermore, hydrogen gas can also be used as the hydrogen donor. Also,it is preferable that the asymmetric reduction reaction be carried outin the presence of a base. Examples of the base include organic tertiaryamines such as trimethylamine, triethylamine, triisopropylamine,1,4-diazabicyclo[2,2,2] octane (DABCO), and1,8-diazabicyclo[5,4,0]undec-7-ene (DBU); and inorganic bases such asLiOH, NaOH, KOH, and K₂CO₃. A suitable base is triethylamine. The baseis used in an excess amount, for example, in an amount of 1 to 100,000times on a molar basis, relative to the amount of the ruthenium complex.In the case of using triethylamine, it is preferable to use the base inan amount of 1 to 10,000 times relative to the amount of the catalyst.

In the combination of a hydrogen donor and a base, when the hydrogendonor is formic acid, it is preferable to use an amine as the base. Inthis case, formic acid and the amine may be added separately to thereaction system, but an azeotropic mixture of formic acid and an aminemay be prepared in advance and used. A preferred example of theazeotropic mixture of formic acid and an amine may be a formicacid-triethylamine (5:2) azeotropic mixture, or the like.

The reaction is usually carried out such that when the hydrogen donor isa liquid, the hydrogen donor can be utilized as a reaction solvent.However, in order to dissolve the raw materials, a non-hydrogen-donatingsolvent such as toluene, tetrahydrofuran, acetonitrile,dimethylformamide, dimethyl sulfoxide, acetone, or methylene chloridecan also be used singly or in mixture as an auxiliary solvent. In thecase of using a formic acid salt or the like, water is used as anauxiliary solvent, together with an organic solvent, in order todissolve the formic acid salt, and the reaction may be carried out in atwo-layer system. In this case, a phase transfer catalyst may be usedtogether in order to accelerate the reaction. Furthermore, in the caseof using hydrogen gas, an alcohol solvent such as methanol, ethanol,isopropanol, trifluoroethanol, or hexafluoro-2-propanol is preferred.

The amount of use of the ruthenium complex as a catalyst is selectedsuch that the molar ratio (S/C) of the substrate (a carbonyl compound oran imine) (S) with respect to ruthenium metal atoms (C) is in the rangeof 10 to 1,000,000, and preferably 100 to 15,000.

In regard to the amount of the hydrogen donor relative to the amount ofthe carbonyl compound or the imine, usually an equimolar amount orgreater is used, and inter alia, when the hydrogen donor is formic acidor a salt thereof, the amount of the hydrogen donor is preferably a1.5-fold molar amount or greater. Furthermore, the hydrogen donor isused in an amount in the range of a 20-fold molar amount or less, andpreferably a 10-fold molar amount or less. On the other hand, when thehydrogen donor is isopropanol or the like, the hydrogen donor is used ina large excess based on the substrate from the viewpoint of reactionequilibrium, and the hydrogen donor is usually used in an amount in therange of a 1000-fold molar amount or less.

The reaction temperature is selected in the range of −20° C. to 100° C.,and preferably 0° C. to 70° C.

The reaction pressure is not particularly limited, and the reaction isusually carried out at 0.05 to 0.2 MPa, and preferably at normalpressure.

Furthermore, in the case of using hydrogen gas, the pressure is usually5 MPa or less.

The reaction time may vary depending on the catalyst ratio, but thereaction time is 1 to 100 hours, and usually 2 to 50 hours.

After the reaction, the optically active substance thus produced can beseparated and purified by general operations such as distillation,extraction, chromatography, and recrystallization.

EXAMPLES

Hereinafter, the present invention will be described in detail by way ofExamples, but the present invention is not intended to be limitedthereto.

The NMR spectra used in the identification of complexes and thedetermination of purity in the following Examples were measured using aMercury Plus 300 4N type apparatus manufactured by Varian TechnologiesJapan, Ltd., or a Bruker BioSpin Avance III 500 System. Furthermore, theGC analysis was carried out using Chirasil-DEX CB (0.25 mm×25 m, 0.25μm) (manufactured by Varian, Inc.), InertCapPure-WAX(0.25 mm×30 m, 0.25μm) (GL Sciences Inc.) and the HPLC analysis was carried out usingCHIRALCEL OJ-H (0.46 mm×25 cm) (manufactured by Daicel ChemicalIndustries, Ltd.).

The symbols in the Examples have the following meanings.

MsDPEN: N-methanesulfonyl-1,2-diphenylethylenediamine

TsDPEN: N-(p-toluensulfonyl)-1,2-diphenylethylenediamine

o-TFTsDPEN: N-(2-trifluorotoluenesulfonyl)-1,2-diphenylethylenediamine

TIPPsDPEN:N-(2,4,6-triisopropylbenzenesulfonyl)-1,2-diphenylethylenediamine

MESsDPEN: N-(2,4,6-trimethylbenzenesulfonyl)-1,2-diphenylethylenediamine

TsCYDN: N-(p-toluenesulfonyl)-1,2-cyclohexanediamine

MIBK: Methyl isobutyl ketone

dppe: Diphenylphosphinoethane

DIPEA: Diisopropylethylamine

However, the diamine in the complex represents that one or two hydrogenatoms of the diamine have been detached.

The term S/C represents the value of the ratio (mole number ofsubstrate/mole number of catalyst).

Example 1 Production ofN-((1R,2R)-1,2-diphenyl-2-(2-(tetrahydro-2H-pyran-2-yloxy)ethylamino)ethyl)-4-methylbenzenesulfonamide

The target compound (B) was produced by the reaction shown below.

In a 50-ml Schlenk tube, 5.0 g (13.65 mmol) of (R,R)-TsDPEN and 2.85 g(2.07 ml) (13.65 mmol) of an alkyl bromide (A) were mixed with 10 ml ofDMSO, and the mixture was allowed to react for 29 hours at 60° C.Subsequently, 50 ml of dichloromethane and 50 ml of a saturated aqueoussolution of NaHCO₃ were introduced into the reaction mixture, and theresulting mixture was stirred. Subsequently, the organic layer wasseparated and was washed two more times with 50 ml of a saturatedaqueous NaHCO₃. Dichloromethane was recovered, and the residue waspurified by silica gel column chromatography. Thus, 4.94 g (72% yield)of the desired compound (B) was obtained.

¹H-NMR(CDCl₃, 300 MHz) δ:

1.43-1.80 (m, 6H), 2.32 (s, 3H), 2.42-2.70 (m, 21-1), 3.40-3.55 (m, 2H),3.70-3.85 (m, 2H), 3.77 (d, 1H), 4.30 (m, 1H), 4.45 (d, 1H), 6.93-7.38(m, 14H)

Example 2 Production ofN-((1R,2R)-2-(2-hydroxyethylamino)-1,2-diphenylethyl)-4-methylbenzenesulfonamide

The target diamine (C) was produced by the reaction shown below.

135 ml of ethanol and 34.5 ml of a 1 M aqueous solution of HCl wereadded to 5.69 g of the compound (B) obtained in Example 1 as describedabove, and the mixture was allowed to react for 2 hours at 40° C.Subsequently, 3.45 g of NaHCO₃ was added to the reaction mixture toneutralize the solution, and then 75 ml of water and 150 ml of diethylether were added thereto. The reaction mixture was separated.Subsequently, 50 ml of water was added, and the ether was removed withan evaporator. Thus, white crystals were precipitated. The reactionmixture was ice-cooled and filtered. The filter cake was washed withwater, and then was dried at 70° C. under reduced pressure. Thus, 4.33 g(92% yield) of the desired diamine (C) was obtained.

¹H-NMR(CDCl₃, 300 MHz) δ:

2.31 (s, 3H), 2.50-2.62 (m, 2H), 3.58-3.75 (m, 2H), 3.79 (d, 1H), 4.40(d, 1H), 6.82-7.41 (m, 14H)

Example 3 Production ofN-((1S,2S)-1,2-diphenyl-2-(2-(tetrahydro-2H-pyran-2-yloxy)ethylamino)ethypmethanesulfonamide

The target compound (D) was produced by the reaction shown below.

In a 50-ml Schlenk tube, 7.0 g (24.1 mmol) of (S,S)-MsDPEN and 5.04 g(3.64 ml, 24.1 mmol) of an alkyl bromide (A) were mixed with 17.6 ml ofDMSO, and the mixture was allowed to react for 30 hours at 60° C.Subsequently, 50 ml of dichloromethane and 50 ml of a saturated aqueoussolution of NaHCO₃ were introduced into the reaction mixture, and theresulting mixture was stirred. Subsequently, the organic layer wasseparated and was washed two more times with 50 ml of a saturatedaqueous NaHCO₃. Dichloromethane was recovered, and the residue waspurified by silica gel column chromatography. Thus, 5.06 g (50% yield)of the desired compound (D) was obtained.

¹H-NMR(CDCl₃, 300 MHz) δ:

1.42-1.90 (m, 6H), 2.20 (d, 3H), 2.50-2.75 (m, 2H), 3.40-3.50 (m, 2H),3.70-3.83 (m, 2H), 3.90 (d, 1H), 4.45 (m, 1H), 4.50 (d, 1H), 7.10-7.30(m, 10H)

Example 4 Production ofN-((1S,2S)-2-(2-hydroxyethylamino)-1,2-diphenylethyl)methanesulfonamide

The target diamine (E) was produced by the reaction shown below.

142 ml of ethanol and 38.7 ml of a 1 M aqueous solution of HCl wereadded to 5.06 g of the compound (D) obtained in Example 3 as describedabove, and the mixture was allowed to react for 2 hours at 40° C.Subsequently, 3.63 g of NaHCO₃ was added to the reaction mixture toneutralize the solution, and then 147 ml of water and 200 ml of diethylether were added thereto. The ether layer was separated. The aqueouslayer was extracted two times with ether, and the ether layers thusobtained were combined, dried over Na₂SO₄, and then concentrated in anevaporator. Thus, 3.62 g (90% yield) of the desired diamine (E) wasobtained.

¹H-NMR(CDCl₃, 300 MHz) δ:

2.40 (s, 3H), 2.50-2.72 (m, 2H), 3.60-3.75 (m, 2H), 3.93 (d, 1H), 4.57(d, 1H), 7.10-7.24 (m, 10H)

Example 5 Production of (4-methylcyclohexa-1,4-dienyl)methanol

The target compound (F) was produced by the reaction shown below.

In a 500-ml four-necked flask, 1.73 g (7.93 mmol) of CoBr₂, 8.4 g (26.3mmol) of ZnI₂, 3.47 g (8.8 mmol) of dppe, and 370 ml of dichloromethanewere introduced, the flask was then purged with nitrogen, and themixture was stirred for 30 minutes at 30° C. Subsequently, 78 ml (53.1g, 780 mmol) of isoprene, 41 ml (39.3 g, 701 mmol) of propargyl alcohol,and 2.2 g (8.53 mmol) of Bu₄NBH₄ were fed to the flask, and theresulting mixture was allowed to react for 7 hours at 30° C.Subsequently, the dichloromethane solution was recovered and wasdistilled under reduced pressure at 160° C. Thus, 27.7 g (32% yield) ofthe desired diene mixture (F) was obtained. The purity of the targetdiene in this mixture as determined by gas chromatography (GC) wasapproximately 98%.

¹H-NMR(CDCl₃, 300 MHz) δ:

1.67 (s, z, 3H), 2.55-2.70 (m, 4H), 4.02 (s, 2H), 5.44 (m, 1H), 5.68 (m,1H)

Example 6 Production of [RuCl₂(1-(bromomethyl)-4-methylbenzene)]₂

The target complex compound (G) was produced by the reaction shownbelow.

4.75 g (38.2 mmol) of the diene (F) obtained in Example 5 as describedabove, 2.0 g (7.65 mmol) of ruthenium trichloride trihydrate, and 0.643g (7.65 mmol) of NaHCO₃ were dissolved in 40 ml of 2-methoxyethanol and4 ml of water, and the solution was allowed to react for 1.5 hours at130° C. Subsequently, the solvent was distilled off in an evaporator,and 52 ml of a concentrated aqueous solution of hydrobromic acid and 4ml of concentrated sulfuric acid were added to the residue. Theresulting mixture was stirred for 4 hours at 100° C. The solutionobtained after the reaction was mixed with dichloromethane, water, and2-methoxyethanol, and the mixture was stirred and left to stand still.Crystals precipitated therefrom were filtered, and thus 1.9 g (79%yield) of the desired complex (G) was obtained.

¹H-NMR(DMSO-d₆, 300 MHz) δ:

2.23 (s, 3H), 4.40 (s, 2H), 5.84 (d, 2H), 6.15 (d, 2H)

Example 7 Production of RuCl(R,R)—O-HT-Tsdpen)

The target complex, RuCl((R,R)—O-HT-Tsdpen), was produced by thereaction shown below.

1.6 g (2.24 mmol) of the arene dimer (G) obtained in Example 6 asdescribed above, 1.53 g (3.73 mmol) of the diamine (C) produced inExample 2, 1.19 g (3.73 mmol) of triethylbenzylammonium iodide(Et₃BnNI), 52.8 ml of dichloromethane, and 52.8 ml of water were mixed,and the mixture was stirred at 35° C. 1.78 g (26.9 mmol) of KOH wasadded to the mixture, and the resulting mixture was allowed to react for3 hours. The organic layer turned into a purple solution. The reactionmixture was left to stand, and then the aqueous layer was removed. 50 mlof water was added to the organic layer, the mixture was stirred andthen left to stand, and the aqueous layer was removed. This operationwas repeated three times, and then 65 ml of a 0.1 M aqueous solution ofHCl was added to the organic layer. The mixture was stirred for 30minutes. Thereafter, 0.034 g of NaHCO₃ was added thereto to neutralizethe solution, and then the mixture was left to stand. Only thedichloromethane layer was collected and dried to solid. This solid waspurified with a silica gel column (eluent: CHCl₃/MeOH=20/1), and thus1.1 g (45% yield) of the desired complex, RuCl(R,R)—O-HT-Tsdpen), wasobtained (the purity determined by liquid chromatography (HPLC) wasapproximately 95%).

¹H-NMR(CD₂Cl₂, 300 MHz) δ:

2.25 (s, 3H), 2.52 (s, 3H), 3.13 (m, 1H), 3.60 (m, 1H), 3.80-4.00 (m,4H), 4.48 (d, J=15.0 Hz, 1H), 4.52 (brs, 1H), 4.95 (d, J=15.0 Hz, 1H),5.45 (d, J=5.2 Hz, 1H), 5.75 (d, J=6.2 Hz, 1H), 6.05 (d, J=5.2 Hz, 1H),6.60 (d, J=6.9 Hz, 2H), 6.65-6.70 (m, 4H), 6.88 (d, J=8.0 Hz, 2H),7.08-7.18 (m, 4H), 7.23 (d, J=8.0 Hz, 2H)

HRMS (ESI):

As C₃₁H₃₃N₂O₃RuS.

Calculated value: [M−Cl]⁺ 615.1258.

Found value: 615.1258.

Example 8 Asymmetric Hydrogen Transfer Reaction of Acetophenone Usingthe Complex RuCl((R,R)—O-HT-Tsdpen) (S/C=2000)

In 50-ml Schlenk tube, 6.5 mg (0.01 mmol) of the complexRuCl(R,R)—O-HT-Tsdpen) produced in Example 7 as described above, 2.32 ml(2.40 g, 20 mmol) of acetophenone, and 10 ml of a formicacid-triethylamine (5:2) azeotropic mixture were mixed, and the Schlenktube was purged with nitrogen. Subsequently, the mixture was allowed toreact for 24 hours at 60° C. An analysis of the reaction liquid wascarried out by GC, and it was found that (R)-1-phenylethanol with 96.3%ee was produced at a conversion rate of 97.5%.

Example 9 Production of RuCl((S,S)—O-HT-Msdpen)

The target complex, RuCl((S,S)—O-HT-Msdpen), was produced by thereaction shown below.

1.7 g (2.38 mmol) of the arene dimer (G) produced in Example 6, 1.325 g(3.96 mmol) of the diamine (E) produced in Example 4, 1.26 g (3.96 mmol)of triethylbenzylammonium iodide (Et₃BnNI), 56 ml of dichloromethane,and 56 ml of water were mixed. While the mixture was stirred at 35° C.,1.78 g (26.9 mmol) of KOH was added to the mixture, and the mixture wasallowed to react for 3 hours. The organic layer turned into a purplesolution. After the mixture was left to stand, the aqueous layer wasremoved, 50 ml of water was added thereto, and the mixture was stirred.Subsequently, the mixture was left to stand and the aqueous layer wasremoved. This operation was carried out three times, and then 68 ml of a0.1 M aqueous solution of HCl was added to the organic layer. Theresulting mixture was stirred for 30 minutes. Thereafter, 1.88 g ofNaHCO₃ was added to neutralize the solution, and then the mixture wasleft to stand. Only the dichloromethane layer was collected and dried tosolid. This solid was purified with a silica gel column (eluent:CHCl₃/MeOH=20/1), and thus 0.98 g (43% yield) of the desired complex,RuCl((S,S)—O-HT-Msdpen), was obtained (the purity determined by HPLC wasapproximately 95%).

¹H-NMR(CD₂Cl₂, 300 MHz) δ:

2.42 ((s, 3H(CH₃ of Ms)), (s, 3H(CH₃ of tolyl))), 3.17-3.25 (m, 1H),3.32-3.40 (m, 1H), 4.00 (d, 1H), 3.90-4.02 (m, 2H), 4.10 (d, 1H),4.20-4.30 (br, 1H), 4.62-4.75 (br, 2H), 5.50 (d, J=6.0 Hz, 1H), 5.63(br, 1H), 5.75 (br, 1H), 5.88 (d, J=6.0 Hz, 1H), 6.84-6.88 (m, 2H),6.98-7.03 (m, 2H), 7.10-7.20 (m, 6H)

HRMS (ESI):

As C₂₆H₂₉N₂O₃RuS.

Calculated value: [M−Cl]⁺ 539.0942.

Found value: 539.0946.

Example 10 Asymmetric Hydrogen Transfer Reaction of Acetophenone UsingRuCl(S,S)—O-HT-Msdpen) (S/C=5000)

In 50-ml Schlenk tube, 2.2 mg (0.0039 mmol) of RuCl((S,S)—O-HT-Msdpen)produced in Example 9 as described above, 2.24 ml (2.31 g, 19.3 mmol) ofacetophenone, and 9.7 ml of a formic acid-triethylamine (5:2) azeotropicmixture were mixed, and the Schlenk tube was purged with nitrogen.Subsequently, the mixture was allowed to react for 24 hours at 60° C. Ananalysis of the reaction liquid was carried out by GC, and it was foundthat (S)-1-phenylethanol with 94.7% ee was produced at a conversion rateof 95.6%.

Example 11 Production of Ru((R,R)—O-HT-Tsdpen) and Hydrogen TransferReaction (In Situ Method) of Acetophenone Using the Complex

The complex Ru((R,R)—O-HT-Tsdpen) was produced by the reaction shownbelow, and a hydrogen transfer reaction of acetophenone was carried outin situ using the complex (in situ method).

18.0 mg (0.025 mmol) of the arene dimer (G) produced in example 6, 17.2mg (0.042 mmol) of the diamine (C) produced in Example 2, 13.4 mg (0.042mmol) of triethylbenzylammonium iodide (Et₃BnNI), 0.6 ml ofdichloromethane, and 0.6 ml of water were mixed, and while the mixturewas stirred at 35° C., 0.02 g (0.3 mmol) of KOH was added to themixture. The resulting mixture was allowed to react for 6 hours. Theorganic layer turned into a purple solution. The reaction liquid wasleft to stand, and 36 μl of the reaction liquid was evacuated from theorganic layer to apply to the reduction for the catalyst ratio wasS/C=2000. The catalyst solution was added to a 15-ml Schlenk tube, and0.58 ml (0.6 g, 5.0 mmol) of acetophenone and 2.5 ml of a formicacid-triethylamine (5:2) azeotropic mixture were incorporated therein.The Schlenk tube was purged with nitrogen, and then the mixture wasallowed to react for 24 hours at 60° C. An analysis of the reactionliquid was carried out by GC, and it was found that (R)-1-phenylethanolwith 96.2% ee was produced at a conversion ratio of 96.5%.

Example 12 Production ofN-((1R,2R)-2-(2-mercaptoethylamino)-1,2-diphenylethyl)-4-methylbenzenesulfonamide

The target mercaptodiamine (H) was produced by the reaction shown below.

In a 50-ml glass autoclave, 5.0 g (13.6 mmol) of (R,R)-TsDPEN, 0.758 g(0.75 ml) (13.6 mmol) of ethylene sulfide, and 25 ml of toluene weremixed, and the mixture was allowed to react for 48 hours at 120° C.Subsequently, toluene was recovered, and the residue was purified bysilica gel column chromatography. Thus, 3.2 g (55% yield) of the desiredmercaptodiamine (H) was obtained.

¹H-NMR(CD₂Cl₂, 300 MHz) δ:

0.58 (br, 2H), 1.94 (s, 3H), 2.10-2.33 (m, 4H), 3.53 (d, 1H), 4.59 (d,1H), 6.36 (br, 1H), 6.69 (d, 2H), 6.79 (m, 8H), 6.93-7.00 (m, 8H), 7.64(d, 2H)

Example 13 Production of the Complex RuCl(R,R)—S-HT-Tsdpen)

The target complex RuCl((R,R)—S-HT-Tsdpen) was produced by the reactionshown below.

0.1 g (0.234 mmol) of the arene dimer (G) produced in Example 6, 0.1 g(0.14 mmol) of the mercaptodiamine (H) produced in Example 12, 0.121 g(163 μl, 0.936 mmol) of DIPEA (Hunig's Base), and 2 ml ofdichloromethane were mixed, and the mixture was allowed to react at 45°C. Subsequently, three times operation of adding water, stirring themixture, subsequently leaving the mixture to stand, washing the organiclayer was carried out, and the organic layer was dried to solid. Thus, asolid mixture containing the desired complex, RuCl((R,R)—S-HT-Tsdpen),was obtained.

HRMS (ESI): As C₃₁H₃₃N₂O₂RuS₂.

Calculated value: [M−Cl]⁺ 631.1028.

Found value: 631.1012.

Example 14 Asymmetric Hydrogen Transfer Reaction of Acetophenone Using aComplex RuCl((R,R)—S-HT-Tsdpen)

A hydrogen transfer reaction of acetophenone was carried out in a formicacid-triethylamine (5:2) azeotrope with S/C=600 at 60° C. After thereaction was carried out for 16 hours, an analysis of the reactionliquid was carried out by GC, and it was found that (R)-1-phenylethanolwith 77.9% ee was produced at a conversion ratio of 67.0%.

Example 15 Asymmetric hydrogen transfer reaction of propiophneone usinga complex RuCl((R,R)—O-HT-Tsdpen)

In a 15-ml Schlenk tube, 3.3 mg (0.005 mmol) of RuCl(R,R)—O-HT-Tsdpen),0.67 ml (0.67 g, 5.0 mmol) of propiophenone, and 2.5 ml of a formicacid-triethylamine (5:2) azeotropic mixture were mixed, and the Schlenktube was purged with nitrogen. Subsequently, the mixture was allowed toreact for 24 hours at 60° C. An analysis of the reaction liquid wascarried out by GC, and it was found that (R)-1-phenylpropan-1-ol with93.7% ee was produced at a conversion rate of 99.7%.

Example 16 Asymmetric hydrogen transfer reaction of propiophenone usinga complex RuCl(S,S)—O-HT-Msdpen)

In a 15-ml Schlenk tube, 2.9 mg (0.005 mmol) of RuCl(S,S)—O-HT-Msdpen),0.67 ml (0.67 g, 5.0 mmol) of propiophenone, and 2.5 ml of a formicacid-triethylamine (5:2) azeotropic mixture were mixed, and the Schlenktube was purged with nitrogen. Subsequently, the mixture was allowed toreact for 24 hours at 60° C. An analysis of the reaction liquid wascarried out by GC, and it was found that (S)-1-phenylpropan-1-ol with92.1% ee was produced at a conversion rate of 95.9%.

Reference Example 1

Asymmetric hydrogen transfer reaction of propiophenone using a knowncomplex RuCl((R,R)-Tsdpen)(mesitylene)

In a 15-ml Schlenk tube, 6.2 mg (0.01 mmol) ofRuCl(R,R)-Tsdpen)(mesitylene), 0.67 ml (0.67 g, 5.0 mmol) ofpropiophenone, and 2.5 ml of a formic acid-triethylamine (5:2)azeotropic mixture were mixed, and the Schlenk tube was purged withnitrogen. Subsequently, the mixture was allowed to react for 24 hours at60° C. An analysis of the reaction liquid was carried out by GC, and itwas found that (R)-1-phenylpropan-1-ol with 93.0% ee was produced at aconversion rate of 52.3%.

Example 17

Asymmetric hydrogen transfer reactions of the ketones (1) to (14)presented in the following Tables 1 and 2 were respectively carried outin the same manner as in Example 15 using RuCl(R,R)—O-HT-Tsdpen), or inthe same manner as in Example 10 using RuCl((S,S)—O-HT-Msdpen). Eachreaction was carried out at the catalyst ratio (S/C) and temperatureindicated in the tables, using a formic acid-triethylamine (5:2)azeotropic mixture as a hydrogen source in an amount such that thesubstrate concentration was 2 mol/L. After a lapse of a predeterminedtime, an analysis of the reaction liquid was carried out by GC, andthereby the conversion rate and the optical purity were determined.

Furthermore, as a comparison, the reaction results obtained in the samemanner as in Reference Example 1 using the known complexRuCl(R,R)-Tsdpen)(mesitylene) are also presented in the right columns ofthe respective tables. In the tables that will be presented hereinafter,the abbreviation “conv.” means the conversion rate of the substrateketone; “selc.” means the selectivity ratio to the target product; “%ee” represents the optical purity; and “S/C” represents the value of theratio (mole number of substrate ketone/mole number of catalyst).

TABLE 1 RuCl(O-HT- RuCl(O-HT- RuCl(Tsdpen) Substrate Ketone Tsdpen)Msdpen) (mesitylene)

(S/C = 1000)  5 h;  100% conv. 93.6% ee (S/C = 1000)  5 h; 99.4% conv.93.2% ee (S/C = 500) 24 h; 53.2% conv. 93.0% ee

(S/C = 1000)  5 h; 99.4% conv. 93.2% ee (S/C = 1000)  5 h; 99.3% conv.92.0% ee (S/C = 500) 24 h; 20.8% conv. 86.6% ee

(S/C = 1000)  5 h; 93.6% conv. 83.6% ee (S/C = 1000)  5 h; 97.8% conv.96.5% ee (S/C = 500) 24 h; 15.0% conv. 65.8% ee

(S/C = 1000)  5 h; 98.5% conv. 93.3% ee (S/C = 1000)  5 h; 98.8% conv.90.5% ee (S/C = 500) 24 h; 28.1% conv. 90.6% ee

(S/C = 1000)  5 h;  100% conv. 97.7% ee (S/C = 1000)  5 h; 99.5% conv.96.8% ee (S/C = 500) 24 h; 25.0% conv. 94.5% ee

(S/C = 1000) 24 h; 98.5% conv. 86.2% ee (S/C = 1000) 24 h; 98.6% conv.87.0% ee (S/C = 500) 24 h; 59.0% conv. 88.0% ee

(S/C = 1000)  5 h; 97.6% conv. 96.0% ee (S/C = 1000)  5 h; 97.1% conv.96.1% ee (S/C = 500)  5 h;  3.8% conv.   0% ee

(S/C = 1000)  5 h;  100% conv. 94.7% ee (S/C = 1000)  5 h;  100% conv.94.9% ee (S/C = 500)  5 h; 65.0% conv. 96.2% ee

TABLE 2 RuCl(O-HT- RuCl(O-HT- RuCl(Tsdpen) Substrate Ketone Tsdpen)Msdpen) (mesitylene)

(S/C = 1000)  5 h; 99.0% conv. >99.9% ee   (S/C = 1000)  5 h; 99.4%conv. 99.8% ee (S/C = 500) 24 h; 99.0% conv. 98.5% ee

(S/C = 1000)  5 h; 99.1% conv. 99.8% ee (S/C = 1000)  5 h; 98.5% conv.99.5% ee (S/C = 500) 24 h; 61.9% conv. 97.8% ee

(S/C = 1000)  5 h; 97.1% conv. 98.4% ee (S/C = 1000)  5 h; 96.5% conv.98.5% ee (S/C = 500) 24 h; 17.4% conv. 90.1% ee

(S/C = 1000) 24 h; 77.1% conv. 94.8% ee (S/C = 1000) 24 h; 69.0% conv.96.7% ee (S/C = 500) 24 h;  1.9% conv. 51.5% ee

(S/C = 500)  24 h; 71.3% conv. (96.0% selc.) 63.0% ee (S/C = 500)  24 h;71.1% conv. (95.3% selc.) 63.7% ee (S/C = 200) 24 h; 38.3% conv. (93.7%selc.) 52.3% ee

(S/C = 1000)  5 h;  100% conv.  (>95% selc.) 97.3% ee (S/C = 1000)  5 h; 100% conv.  (>95% selc.) 96.4% ee (S/C = 500)  5 h; 97.7% conv.   (66%selc.) 90.9% ee

The leftmost columns of Table 1 and Table 2 indicate the kind of ketonesused as the substrate, and the next right columns indicate the resultsobtained when the complex RuCl((R,R)—O-HT-Tsdpen) of the presentinvention was used. The next right columns indicate the results obtainedwhen the complex RuCl(S,S)—O-HT-Msdpen) of the present invention wasused, and the rightmost columns indicate the results obtained when theknown complex RuCl((R,R)-Tsdpen)(mesitylene) was used as a ComparativeExample.

As such, the ruthenium complexes of the present invention having aheteroatom introduced into the chain-like moiety exhibit very highactivities and selectivities, and the ruthenium complexes can produceoptically active cyclic alcohols by reducing cyclic ketones, such as theketones (9) to (12) which could not be hitherto efficiently reduced withhydrogenation catalysts or the like, or can produce optically activediols by reducing ketones having a hydroxyl group, such as the ketone(7). Similarly, the ruthenium complexes can produce optically activealcohols having a halogen substituent by hydrogenating ketones having ahalogen substituent (particularly, ketones having a halogen substituentat the α-position), such as the ketone (14), which are unstable to basesand are therefore not easily reducible with conventional hydrogenationcatalysts or the like. Thus, the ruthenium complexes according to thepresent invention are highly useful.

Example 18 Asymmetric Hydrogen Transfer Reaction of Benzil Using ComplexRuCl(R,R)—O-HT-Tsdpen) (S/C=2000)

Benzil was asymmetrically reduced according to the following reactionformula.

In a 50-ml Schlenk tube, 3.5 mg (0.005 mmol) of RuCl((R,R)—O-HT-Tsdpen),2.1 g (10 mmol) of benzil, 5 ml of a formic acid-triethylamine (5:2)azeotropic mixture, and 10 ml of DMF were mixed, and the Schlenk tubewas purged with nitrogen. Subsequently, the mixture was allowed to reactfor 5 hours at 60° C. An analysis of the reaction liquid was carried outby GC and HPLC, and it was found that hydrobenzoin was produced at theratio of ((S,S) form: (R,R) form:meso form=88.1:0.9:11.0) at aconversion rate of 90.0%. The enantiomeric excess of the (S,S) form andthe (R,R) form in this case is 98.0% ee.

Example 19 Asymmetric Hydrogen Transfer Reaction of(E)-N-(3,4-dihydronaphthalen-1(2H)-ylidene)-1-phenylmethanamine

In a 50-ml Schlenk tube, 3.3 mg (0.005 mmol) (S/C=300) ofRuCl(R,R)—O-HT-Tsdpen), 0.35 g (1.5 mmol) of the indicated imine, 3 mlof dichloromethane, and 0.75 ml of a formic acid-triethylamine (5:2)azeotropic mixture were mixed, and the mixture was allowed to react for24 hours at 30° C. The yield and optical purity of the product weremeasured by a GC analysis, and as a result, optically activeN-benzyl-1-(1,2,3,4-tetrahydronaphthyl)amine, which was the targetamine, was obtained with a yield of 70.0% and an optical purity of 70%ee.

Example 20 Asymmetric Hydrogenation of 4-Chromanone

In a 50-ml autoclave, 3.3 mg (0.005 mmol, S/C=1000) ofRuCl(R,R)—O-HT-Tsdpen) was placed, and the autoclave was purged withnitrogen. Subsequently, 0.74 g (5.0 mmol) of 4-chromanone and 4.4 ml ofmethanol were added thereto, and the pressure was raised with hydrogenup to 3.0 MPa. Subsequently, the mixture was stirred for 18 hours at 60°C. The reaction liquid was subjected to a GC analysis, and as a result,(R)-4-chromanol was obtained at a conversion rate of 98.6% with anoptical purity of 99.1% ee.

Example 21 Asymmetric Hydrogenation of α-Tetralone

In a 50-ml autoclave, 3.3 mg (0.005 mmol, S/C=1000) ofRuCl((R,R)—O-HT-Tsdpen) was placed, and the autoclave was purged withnitrogen. Subsequently, 0.73 g (5.0 mmol) of α-tetralone and 4.4 ml ofmethanol were added thereto, then hydrogen gas was charged to 3.0 MPa.Subsequently, the mixture was stirred for 20 hours at 60° C. Thereaction liquid was subjected to a GC analysis, and as a result,(R)-1-tetralol was obtained at a conversion rate of 52.0% with anoptical purity of 99.3% ee.

Example 22 Asymmetric hydrogenation of 1-indanone

In a 50-ml autoclave, 3.3 mg (0.005 mmol, S/C=1000) ofRuCl(R,R)—O-HT-Tsdpen) was placed, and the autoclave was purged withnitrogen. Subsequently, 0.66 g (5.0 mmol) of 1-indanone and 4.4 ml ofmethanol were added thereto, then hydrogen gas was charged to 3.0 MPa.Subsequently, the mixture was stirred for 20 hours at 60° C. Thereaction liquid was subjected to a GC analysis, and as a result,(R)-1-indanol was obtained at a conversion rate of 58.6% with an opticalpurity of 97.8% ee.

Example 23 The hydrogenation of methyl benzoate using RuCl((R,R)—O-HT-Tsdpen)

In a 50-ml autoclave, 13.5 mg (0.020 mmol, S/C=50) ofRuCl(R,R)—O-HT-Tsdpen) was placed, and the autoclave was purged withnitrogen. Subsequently, 1.8 ml of tetrahydrofuran and 0.14 g (1.0 mmol)of methyl benzoate, 0.2 ml (0.20 mmol) of the 1.0M tetrahydrofuransolution of potassium tert-Butoxide were added thereto, then hydrogengas was charged to 5.0 MPa. Subsequently, the mixture was stirred for 15hours at 60° C. The reaction liquid was subjected to a GC analysis, andas a result, benzyl alcohol was obtained at a conversion rate of 90.4%with an selectivity of 78.9%.

Reference Example 2

In order to investigate the effects of the heteroatom in the novelruthenium-diamine complexes having a heteroatom introduced into thechain-like moiety that links the aromatic compound (arene) portion andthe diamine moiety that are coordinated to ruthenium, which has beennewly discovered in this invention, the following complex which does nothave any heteroatom, and in which the chain-like moiety is composed onlyof carbon atoms, was separately synthesized, and a comparison ofactivity was made.

The complex was produced by making reference to the production methoddescribed in the Non-Patent Literature 5 (J. Am. Chem. Soc. 127 (2005),p. 7318). This newly produced complex will be hereinafter referred to asRuCl(p-Tol-C₄-teth-Tsdpen).

¹H-NMR(CDCl₃, 300 MHz) δ:

1.82-2.04 (m, 2H), 2.04-2.31 (m, 5H), 2.26 (s, 3H), 2.53 (s, 3H),2.89-2.71 (m, 2H), 3.10-3.16 (m, 1H), 3.47-3.56 (m, 1H), 3.80 (dd,J=11.1, 12.1 Hz, 1H), 3.99 (d, J=11.1 Hz, 1H), 4.77 (m, 1H), 5.32 (d,J=5.5 Hz, 2H), 5.38 (d, J=6.3 Hz, 2H), 5.55 (d, J=6.3 Hz, 1H), 6.20 (d,J=5.5 Hz, 1H), 6.61 (d, J=7.2 Hz, 1H), 6.59-6.62 (m, 2H), 6.71-6.81 (m,4H), 6.83-6.91 (m, 3H), 7.03-7.12 (m, 3H), 7.18 (d, J=8.4 Hz, 2H);

HRMS (ESI):

As C₃₂H₃₅N₂O₂SRu.

Calculated value: [M−Cl]⁺ 613.1457.

Found value: 613.1473.

Example 24

In order to investigate the activities of the complexRuCl((R,R)—O-HT-Tsdpen) having a heteroatom in the side chain moiety andof the complex RuCl(p-Tol-C₄-teth-Tsdpen) produced in Reference Example2, in which the side chain moiety is composed only of carbon atoms,hydrogen transfer reactions of acetophenone were carried out at catalystratios such as indicated in the following table. The reactions werecarried out at the catalyst ratios indicated in the following Table 3and at 60° C., using a formic acid-triethylamine (5:2) azeotropicmixture as a hydrogen source in an amount such that the substrateconcentration was 2 mol/L. After a lapse of a predetermined time, ananalysis of the reaction liquids was carried out by GC, and thereby theconversion rate and the optical purity were determined.

The results are presented in the following Table 3.

TABLE 3 Catalytic Ratio (S/C) RuCl(O-HT-Tsdpen)RuCl(p-Tol-C₄-teth-Tsdpen) 1000 (20 h) 99.0% conv. 96.3% ee (20 h) 99.0%conv. 96.3% ee 5000 (24 h) 94.8% conv. 96.2% ee (24 h) 94.6% conv. 96.3%ee 10000 (24 h) 71.5% conv. 96.1% ee (24 h) 40.0% conv. 94.9% ee (48 h)91.5% conv. 96.2% ee (48 h) 43.1% conv. 94.4% ee (72 h) 95.2% conv.96.2% ee (72 h) — 15000 (24 h) 61.0% conv. 96.1% ee (24 h) 6.5% conv.79.7% ee (48 h) 87.3% conv. 96.3% ee (48 h) — (72 h) 94.1% conv. 96.3%ee

As such, the complex RuCl(O-HT-Tsdpen) having a heteroatom in the sidechain moiety, and the complex RuCl(p-Tol-C₄-teth-Tsdpen) in which theside chain moiety is composed only of carbon atoms, both exhibit highactivities in the acetophenone reduction reaction as compared with theconventional hydrogen transfer type complexes, and both of the complexesgave equally satisfactory results in the reactions at catalyst ratios ofup to S/C=5000. However, when the catalyst ratio was increased toS/C=10,000, the reaction carried out using the complex RuCl(O-HT-Tsdpen)of the present invention was almost completed, but in the reaction usingthe complex RuCl(p-Tol-C₄-teth-Tsdpen), the conversion rate was onlyaround 40%, while the reaction was stopped due to deactivation of thecatalyst. Furthermore, when the catalyst ratio was increased toS/C=15,000, the reaction carried out using the complex RuCl(O-HT-Tsdpen)of the present invention was likewise almost completed, but the reactionhardly proceeded when the complex RuCl(p-Tol-C₄-teth-Tsdpen) was used.Therefore, when a comparison was made between these two complexes whichrespectively have an equal length of the side chain that links theskeleton on the arene or links the arene and diamine portions, butdifferent elements constituting the side chain, such as oxygen atoms andcarbon atoms, it was found that the complex RuCl(O-HT-Tsdpen) of thepresent invention having an oxygen atom among the atoms constituting theside chain exhibits a very high catalytic activity even when used in avery small amount.

Example 25 Production of Ru(BF₄)((R,R)—O-HT-Tsdpen)

In a 150-ml Schlenk tube, 0.52 g (0.8 mmol, 1 eq) ofRuCl((R,R)—O-HT-Tsdpen), 0.187 g (0.96 mmol, 1.2 eq) of AgBF₄, 15 ml ofdichloromethane, and 15 ml of methanol were mixed, and the mixture wasstirred for one hour at room temperature. The reaction solution wasfiltered through Celite, and the filtrate was dried to solid. Thus, 0.55g (98% yield) of the desired complex, RuBF₄((R,R)—O-HT-Tsdpen), wasobtained.

¹H-NMR(CD₃OD, 300 MHz) δ:

2.12 (s, 3H), 2.46 (s, 3H), 3.35-3.60 (m, 4H), 3.60-3.80 (m, 1H),3.95-4.10 (m, 3H), 4.70-4.80 (m, 1H), 5.84 (d, 1H), 5.89 (d, 1H), 5.99(d, 1H), 6.20 (d, 1H), 6.46-7.50 (m, 14H)

HRMS (ESI):

As C₃₁H₃₃BF₄N₂O₃RuS.

Calculated value: [M−BF₄]⁺ 615.1250.

Found value: 615.1271.

Example 26 Production of Ru(OTf)((R,R)—O-HT-Tsdpen)

In a 150-ml Schlenk tube, 0.52 g (0.8 mmol, 1 eq) ofRuCl(R,R)—O-HT-Tsdpen), 0.247 g (0.96 mmol, 1.2 eq) of AgOTf, 15 ml ofdichloromethane, and 15 ml of methanol were mixed, and the mixture wasstirred for one hour at room temperature. The reaction solution wasfiltered through Celite, and the filtrate was dried to solid. Thus, 0.59g (96% yield) of the desired complex, RuOTf(R,R)—O-HT-Tsdpen), wasobtained.

¹H-NMR(CD₃OD 300 MHz) δ:

2.13 (s, 3H), 2.47 (s, 3H), 3.35-3.60 (m, 4H), 3.60-3.80 (m, 1H),3.95-4.10 (m, 3H), 4.70-4.80 (m, 1H), 5.84 (d, 1H), 5.89 (d, 1H), 5.99(d, 1H), 6.20 (d, 1H), 6.46-7.50 (m, 14H)

HRMS (ESI):

As C₃₂H₃₃F₃N₂O₆RuS₂.

Calculated value: Positive side [M−TfO]⁺ 615.1250.

Negative side [TfO]⁻ 148.9526.

Found value: Positive side [M−TfO]⁺ 615.1258.

Negative side [TfO]⁻ 148.9521.

Example 27 Production of Ru(SbF₆)((R,R)—O-HT-Tsdpen)

In a 150-ml Schlenk tube, 0.52 g (0.8 mmol, 1 eq) ofRuCl((R,R)—O-HT-Tsdpen), 0.330 g (0.96 mmol, 1.2 eq) of AgSbF₆, 15 ml ofdichloromethane, and 15 ml of methanol were mixed, and the mixture wasstirred for one hour at room temperature. The reaction solution wasfiltered through Celite, and the filtrate was dried to solid. Thus, 0.65g (95% yield) of the desired complex, RuSbF₆((R,R)—O-HT-Tsdpen), wasobtained.

¹H-NMR(CD₃OD, 300 MHz) δ:

2.16 (s, 3H), 2.42 (s, 3H), 3.30-3.60 (m, 4H), 3.60-3.80 (m, 1H),4.00-4.15 (m, 3H), 4.70-4.80 (m, 1H), 5.83 (d, 1H), 5.91 (d, 1H), 5.97(d, 1H), 6.19 (d, 1H), 6.48-7.25 (m, 14H)

HRMS (ESI):

As C₃₁H₃₃F₆N₂O₃RuSSb.

Calculated value: [M−SbF₆]⁺ 615.1250.

Found value: 615.1251.

Example 28 Production of Ru(CF₃COO)((R,R)—O-HT-Tsdpen)

In a 150-ml Schlenk tube, 0.52 g (0.8 mmol, 1 eq) ofRuCl((R,R)—O-HT-Tsdpen), 0.212 g (0.96 mmol, 1.2 eq) of CF₃COOAg, 15 mlof dichloromethane, and 15 ml of methanol were mixed, and the mixturewas stirred for one hour at room temperature. The reaction solution wasfiltered through Celite, and the filtrate was dried to solid. Thus, 0.58g (99% yield) of the desired complex, Ru(CF₃COO)((R,R)—O-HT-Tsdpen), wasobtained.

HRMS (ESI):

As C₃₃H₃₃F₃N₂O₆RuS.

Calculated value: [M−CF₃COO]⁺ 615.1250.

Found value: 615.1243.

Example 29 Production of Ru(CH₃COO)((R,R)—O-HT-Tsdpen)

In a 150-ml Schlenk tube, 0.52 g (0.8 mmol, 1 eq) ofRuCl((R,R)—O-HT-Tsdpen), 0.16 g (0.96 mmol, 1.2 eq) of CH₃COOAg, 15 mlof dichloromethane, and 15 ml of methanol were mixed, and the mixturewas stirred for one hour at room temperature. The reaction solution wasfiltered through Celite, and the filtrate was dried to solid. Thus, 0.50g (92% yield) of the desired complex, Ru(CH₃COO)((R,R)—O-HT-Tsdpen), wasobtained.

¹H-NMR(d⁶-DMSO, 300 MHz) δ:

1.89 (s, 3H), 2.18 (s, 3H), 2.26 (s, 3H), 3.00-4.00 (m, 4H), 3.85 (d,1H), 4.03 (t, 1H), 4.62 (d, 1H), 4.85 (d, 1H), 4.03 (t, 1H), 5.53 (m,2H), 5.97 (m, 2H), 6.48-7.60 (m, 14H), 10.07 (m, 1H),

HRMS (ESI):

As C₃₃H₃₆N₂O₅RuS.

Calculated value: [M−CH₃COO]⁺ 615.1250.

Found value: 615.1240.

Example 30 Production of Ru(B(C₆F₅)₄)((R,R)—O-HT-Tsdpen)

In a 150-ml Schlenk tube, 0.40 g (0.61 mmol, 1 eq) ofRuCl(R,R)—O-HT-Tsdpen), 0.5 g (0.74 mmol, 1.2 eq) of LiB(C₆F₅)₄, 11 mlof dichloromethane, and 11 ml of methanol were mixed, and the mixturewas stirred for one hour at room temperature. The reaction solution wasfiltered through Celite, and the filtrate was dried to solid. Thus, 0.74g (93% yield) of the desired complex, Ru(B(C₆F₅)₄)((R,R)—O-HT-Tsdpen),was obtained.

¹H-NMR(CD₃OD, 300 MHz) δ:

2.15 (s, 3H), 2.39 (s, 3H), 3.10-3.23 (m, 2H), 3.40-3.58 (m, 2H),3.70-4.00 (m, 2H), 3.90 (t, 1H), 4.15 (d, 1H), 4.62 (m, 1H), 5.60-5.95(m, 4H), 6.52-7.25 (m, 14H) ¹⁹F-NMR(CD₃OD) δ:

−168.8, −164.9, −133.0

HRMS (ESI):

As C₅₅H₃₃BF₂₀N₂O₃RuS.

Calculated value: Positive side [M−B(C₆F₅)₄]⁺ 615.1250.

Negative side [B(C₆F₅)₄]⁻ 678.9776.

Found value: Positive side [M−B(C₆F₅)₄]⁺ 615.1254.

Negative side [B(C₆F₅)₄]⁻ 678.9774.

Example 31 Asymmetric Hydrogen Transfer Reaction of Acetophenone UsingComplex Ru(BF₄)((R,R)—O-HT-Tsdpen) (S/C=1000)

In 15-ml Schlenk tube, 3.5 mg (0.005 mmol) of the complexRu(BF₄)((R,R)—O-HT-Tsdpen) produced in Example 25 as described above,0.58 ml (0.6 g, 5 mmol) of acetophenone, and 2.5 ml of a formicacid-triethylamine (5:2) azeotropic mixture were mixed, and the Schlenktube was purged with nitrogen. Subsequently, the mixture was allowed toreact for 5 hours at 60° C. An analysis of the reaction liquid wascarried out by GC, and it was found that (R)-1-phenylethanol with 96.2%ee was produced at a conversion rate of 96.5%.

Example 32 Asymmetric Hydrogenation Reaction of 2-Methylquinoline UsingComplex Ru(BF₄)((R,R)—O-HT-Tsdpen)

In a 100-ml autoclave, 17.5 mg (0.025 mmol) ofRu(BF₄)((R,R)—O-HT-Tsdpen) was placed, and the autoclave was purged withnitrogen. Subsequently, 0.34 ml (0.36 g, 2.5 mmol) of 2-methylquinolineand 1.4 ml of HFIP (hexafluoro-2-propanol) were added thereto, thenhydrogen gas was charged to 5.0 MPa. Subsequently, the mixture wasstirred for 19 hours at 40° C. The reaction liquid was subjected to a GCanalysis, and as a result, it was found that1,2,3,4-tetrahydroquinaldine, which is a reduced form, was produced at aconversion rate of 93.8%, with an optical purity of 86% ee.

Example 33

Asymmetric hydrogenation reactions were carried out in the same manneras in Example 32, by respectively using Ru(BF₄)((R,R)—O-HT-Tsdpen),Ru(OTf)((R,R)—O-HT-Tsdpen), Ru(SbF₆)((R,R)—O-HT-Tsdpen),Ru(CF₃COO)((R,R)—O-HT-Tsdpen), Ru(CH₃COO)((R,R)—O-HT-Tsdpen) orRu(B(C₆F₅)₄)((R,R)—O-HT-Tsdpen) as the catalyst, and using HFIP ormethanol as the solvent. 2-Methylquinoline was used as the substrate forthe reactions, and the reactions were respectively carried out for 19hours. The results are presented in the following Table 4.

TABLE 4 Conversion Assymetric Catalyst (S/C = 100) Solvent rate (%conv.) yield (% ee) Ru(BF₄)(O-HT-Tsdpen) HFIP 93.8 86 MeOH 95.7 58Ru(OTf)(O-HT-Tsdpen) HFIP 98.1 90 MeOH 84.3 42 Ru(SbF₆)(O-HT-Tsdpen)HFIP 97.2 86 MeOH 85.8 46 Ru(CF₃COO)(O-HT-Tsdpen) HFIP 98.4 90 MeOH 79.135 Ru(CH₃COO)(O-HT-Tsdpen) HFIP 98.8 91 MeOH 56.2 16Ru(B(C₆F₅)₄)(O-HT-Tsdpen) HFIP 92.1 90 MeOH 51.4 28

Example 34 Asymmetrichydrogenation Reaction of 2-Methylquinoxaline UsingComplex Ru(BF₄)((R,R)—O-HT-Tsdpen)

In a 100-ml autoclave, 17.5 mg (0.025 mmol) ofRu(BF₄)((R,R)—O-HT-Tsdpen) was placed, and the autoclave was purged withnitrogen. Subsequently, 0.32 ml (0.36 g, 2.5 mmol) of2-methylquinoxaline and 1.4 ml of HFIP (hexafluoro-2-propanol) wereadded thereto, then hydrogen gas was charged to 5.0 MPa. Subsequently,the mixture was stirred for 20 hours at 50° C. The reaction liquid wassubjected to a GC analysis, and as a result, it was found that2-methyl-1,2,3,4-tetrahydroquinoxaline, which is a reduced form, wasproduced at a conversion rate of 68.5%, with an optical purity of 48%ee.

Example 35

Asymmetrichydrogenation reactions were carried out in the same manner asin Example 34, by respectively using Ru(BF₄)((R,R)—O-HT-Tsdpen),Ru(OTf)((R,R)—O-HT-Tsdpen), Ru(SbF₆)((R,R)—O-HT-Tsdpen) as the catalyst,in the BEEP solvent. 2-Methylquinoxaline was used as the substrate forthe reactions, and the reactions were respectively carried out for 20hours. The results are presented in the following Table 5.

TABLE 5 Conversion Assymetric Catalyst (S/C = 100) Solvent rate (%conv.) yield (% ee) Ru(BF₄)(O-HT-Tsdpen) HFIP 68.5 48Ru(OTf)(O-HT-Tsdpen) HFIP 66.0 46 Ru(SbF₆)(O-HT-Tsdpen) HFIP 65.2 46

Example 36 Production of2-((4-methylcyclohexa-1,4-dienyl)methoxy)ethanol and2((5-methylcyclohexa-1,4-dienyl)methoxy)ethanol

7.74 g (0.019 mol) of 1,2-bis(diphenylphosphino)ethane, 4.05 g (0.019mol) of cobalt bromide, 11.82 g (0.037 mol) of zinc iodide, and 2.42 g(0.037 mol) of zinc were added to 460 ml of THF, and the solution wasstirred for 15 minutes at 70° C. The solution was cooled to roomtemperature, and 74.89 g (1.10 mol) of isoprene was added thereto.Subsequently, 92.70 g (0.93 mol) of alkynyl alcohol was slowly addeddropwise to the mixture in a water bath. The resulting mixture wasstirred for one hour at 35° C., and then the solvent was distilled offunder a reduced pressure. To the residue thus obtained, 460 ml oftoluene and 460 ml of water were added (stirred for 10 minutes, and leftto stand for 10 minutes). The mixture was filtered through Celite in anitrogen atmosphere, and then the organic layer of solution thusobtained was separated. The solvent was distilled off under reducedpressure, and the crude product thus obtained was purified by Claisendistillation (101° C.-113° C., at 3 torr). Thus, 106.6 g of dienealcohol was obtained as a colorless oil. Yield 68.5%(1,4-type/1,5-type=91/9).

¹H-NMR(CDCl₃, 300 MHz) δ:

1.68 (s, 3H), 2.31 (brs, 1H), 2.64 (brs, 4H), 3.48-3.52 (m, 2H),3.70-3.75 (m, 2H), 3.93 (s, 2H), 5.43-5.45 (m, 1H), 5.70-5.71 (m, 1H);

HRMS (ESI):

As C₁₀H₁₆O₂.

Calculated value: [M+H]⁺ 167.1430.

Found value: 167.1432.

Example 37 Production of 2-((4-methylcyclohexa-1,4-dienyl)methoxy)ethyl4-methylbenzenesulfonate and2((5-methylcyclohexa-1,4-dienyl)methoxy)ethyl 4-methylbenzenesulfonate

100.00 g (0.59 mol) of the diene alcohol obtained in Example 36, 90.29 g(0.89 mol) of triethylamine, and 73.20 g (0.89 mol) of 1-methylimidazolewere dissolved in 400 ml of toluene. In an ice bath, a toluene solution(400 ml) of 130.33 g (0.68 mol) of p-toluenesulfonyl chloride was slowlyadded dropwise to the solution, and then the resulting mixture wasstirred for one hour at room temperature. Water was added thereto, andthe organic layer was separated. The obtained organic layer was washedsequentially with 15% sulfuric acid, water, and a saturated aqueoussodium hydrogen carbonate. The solvent was distilled off under reducedpressure, and thus 188.01 g of the desired tosylate was obtained as acolorless oil. Yield 98.1% (1,4-type/1,5-type=91/9).

¹H-NMR(CDCl₃, 300 MHz) δ:

1.67 (s, 3H), 2.44 (s, 3H), 2.58 (brs, 4H), 3.58-3.55 (m, 2H), 3.84 (s,2H), 4.18-4.14 (m, 2H), 5.41-5.40 (m, 1H), 5.64-5.63 (m, 1H), 7.33 (d,J=8.3 Hz, 1H), 7.80 (d, J=8.3 Hz, 1H);

HRMS (ESI):

As C₁₇H₂₂O₄S.

Calculated value: [M+H]⁺ 323.1312.

Found value: 323.1325.

Example 38 Production of4-methyl-N-((1R,2R)-2-(2-((4-methylcyclohexa-1,4-dienyl)methoxy)ethylamino)-1,2-diphenylethyl)benzenesulfonamidehydrochloride and4-methyl-N-((1R,2R)-2-(2-((5-methylcyclohexa-1,4-dienyl)methoxy)ethylamino)-1,2-diphenylethyl)benzenesulfonamidehydrochloride

2.2 g (6.9 mmol) of the tosylate obtained in Example 37 was dissolved in10 ml of toluene, and 0.90 g (6.9 mmol) of DIPEA and 2.53 g (6.9 mmol)of (R,R)-TsDPEN were added to the solution. The resulting mixture wasstirred for 27 hours at 135° C. Water was added thereto, and the organiclayer was separated. The obtained organic layer was washed with water,then 20% hydrochloric acid was added thereto. The resulting mixture wasstirred for one hour at room temperature, and then was precipitatedunder ice cooling. Crystals precipitated therefrom were collected byfiltration, and thus 3.14 g of the desired diamine hydrochloride wasobtained as a white solid. Yield 82.3%.

¹H-NMR(CDCl₃, 300 MHz) δ:

1.43-1.80 (m, 6H), 2.32 (s, 3H), 2.42-2.70 (m, 2H), 3.40-3.55 (m, 2H),3.70-3.85 (m, 2H), 3.77 (d, 1H), 4.30 (m, 1H), 4.45 (d, 1H), 6.93-7.38(m, 14H);

HRMS (ESI):

As C₃₁H₃₇N₂O₃S.

Calculated value: [M−Cl]⁺ 517.2519.

Found value: 517.2523.

Example 39 Production of RuCl((R,R)—O-HT-Tsdpen)

25.15 g (45.20 mmol) of the diamine hydrochloride produced in Example 38was dissolved in 375 ml of 3-methoxypropanol and 75 ml of water. 10.74 g(41.09 mmol) of ruthenium trichloride trihydrate and 3.45 g (41.09 mmol)of sodium hydrogen carbonate were added to the solution, and theresulting mixture was stirred for 45 minutes at 120° C.3-methoxypropanol was recovered, and then 425 ml of MIBK and 16.63 g(164.4 mmol) of triethylamine were added to the reaction liquid, and themixture was stirred for one hour at 60° C. Heptane was added to theresidue which washed by 0.3 M hydrochloric acid, and the residue wassubjected to crystallization. And thus 22.26 g of the desired Ru complexwas obtained. Yield 83.3%.

¹H-NMR(CDCl₃, 500 MHz) δ:

2.26 (s, 3H), 2.52 (s, 3H), 3.14-3.10 (m, 1H), 3.60-3.56 (m, 1H),3.98-3.91 (m, 4H), 4.58-4.45 (m, 2H), 4.96-4.92 (m, 1H), 5.46 (brd,J=3.6 Hz, 1H), 5.62 (d, J=6.3 Hz, 1H), 5.75 (d, J=6.3 Hz, 1H), 6.05(brd, J=3.6 Hz, 1H), 6.60 (d, J=7.3 Hz, 2H), 6.75-6.69 (m, 4H), 7.21 (d,J=8.0 Hz, 2H), 6.84 (d, J=7.3 Hz, 1H), 6.88 (d, J=8.0 Hz, 2H), 7.17-7.08(m, 4H);

HRMS (ESI):

As C₃₁H₃₄ClN₂O₃RuS.

Calculated value: [M+H]⁺ 651.1057.

Found value: 651.1008.

Example 40 Production of RuCl((R,R)—O-HT-Tsdpen)-dimer

0.50 g (0.904 mmol) of the diamine hydrochloride produced in Example 38was dissolved in 7.5 ml of 2-methoxypropanol and 1.5 ml of water. 0.23 g(0.86 mmol) of ruthenium trichloride trihydrate and 0.072 g (0.86 mmol)of sodium hydrogen carbonate were added to the solution, and theresulting mixture was stirred for 90 minutes at 120° C.2-Methoxypropanol was recovered, and then 15 ml of diethyl ether wasadded to the residue. Crystals precipitated therefrom were collected byfiltration, and thus 0.60 g of the desired Ru complex was obtained.Yield 96.5%.

¹H-NMR(DMSO-d₆, 300 MHz) δ:

2.10-2.15 (m, 3H), 2.20 (s, 3H), 2.70-3.00 (m, 2H), 3.60-3.90 (m, 2H),4.35-4.42 (m, 2H), 4.70 (m, 1H), 4.85 (m, 1H), 5.75-6.10 (m, 4H),6.88-7.35 (m, 14H), 8.90 (brd, 1H), 8.95-9.15 (m, 2H), 10.00 (brd, 1H);

Example 41 Asymmetric Hydrogen Transfer Reaction of Acetophenone UsingComplex RuCl((R,R)—O-HT-Tsdpen)-dimer (S/C=1000)

In a 50-ml Schlenk tube, 3.6 mg (0.005 mmol) of the complexRuCl(R,R)—O-HT-Tsdpen)-dimer produced in Example 40 as described above,0.58 ml (0.60 g, 5 mmol) of acetophenone, and 2.5 ml of a formicacid-triethylamine (5:2) azeotropic mixture were mixed, and the Schlenktube was purged with nitrogen. Subsequently, the mixture was allowed toreact for 5 hours at 60° C. An analysis of the reaction liquid wascarried out by GC, and it was found that (R)-1-phenylethanol with 96.2%ee was produced at a conversion rate of 97.5%.

Example 42 Production ofN-((1R,2R)-2-(2-((4-methylcyclohexa-1,4-dienyl)methoxy)ethylamino)-1,2-diphenylethyl)-2-(trifluoromethyl)benzenesulfonamide hydrochloride

8.07 g (26.1 mmol) of the tosylate obtained in Example 37 was dissolvedin 31.6 ml of toluene, and 3.38 g (26.2 mmol) of DIPEA, 10.00 g (23.8mmol) of (R,R)-o-TFTsDPEN, and 4.34 g (26.2 mmol) of potassium iodidewere added to the solution. The resulting mixture was stirred for 6hours at 135° C. The reaction liquid was concentrated, and was purifiedby silica gel column chromatography. Thus, 10.1 g of diamine J wasobtained. Yield 74.5%. Subsequently, 110 ml of dichloromethane and 65.3ml of an HCl-methanol solution (1 N) were added to 10.1 g (17.7 mmol) ofthe diamine J, and the resulting mixture was stirred for 0.5 hours.Subsequently, the solvent was removed, and thus 11.1 g of the desireddiamine hydrochloride K was obtained. Yield 93.9%.

¹H-NMR(DMSO-d₆, 300 MHz) δ:

1.62 (m, 3H), 2.60 (s, 3H), 2.78-3.12 (m, 2H), 3.52-3.70 (m, 2H), 3.86(s, 2H), 4.75 (m, 1H), 4.92 (m, 1H), 5.40 (m, 1H), 5.68 (m, 1H),6.75-7.35 (m, 10H), 7.40 (t, 1H), 7.50 (t, 1H), 7.60 (d, 1H), 7.75 (d,1H), 8.90 (m, 1H), 8.98 (brd, 1H), 9.92 (brd, 1H);

¹⁹F-NMR(DMSO-d₆) δ:

−57.16

HRMS (ESI):

As C₃₁H₃₃N₂O₃F₃S.HCl.

Calculated value: [M−Cl]⁺ 571.2237.

Found value: 571.2244.

Example 43 Production of RuCl(R,R)—O-HT-o-TFTsdpen)

5.0 g (8.25 mmol) of the diamine hydrochloride produced in Example 42was dissolved in 66 ml of 3-methoxypropanol and 22 ml of water. 1.79 g(6.86 mmol) of ruthenium trichloride trihydrate and 0.58 g (6.86 mmol)of sodium hydrogen carbonate were added to the solution, and theresulting mixture was stirred for 2 hours at 120° C. 50 ml of3-methoxypropanol was recovered, and then 75 ml of MIBK and 2.78 g(27.45 mmol) of triethylamine were added to the residue. The mixture wasstirred for one hour at 60° C. 0.3 M hydrochloric acid was addedthereto, and the organic layer was separated. The obtained organic layerwas washed two times with water. After washing, about 60 ml of thesolvent was recovered, and 85 ml of heptane was added to the residue.The mixture was subjected to crystallization. Crystals precipitatedtherefrom were collected by filtration, and thus 4.60 g of the desiredRu complex was obtained. Yield 95.2%.

¹H-NMR(CD₂Cl₂, 300 MHz) δ:

2.50 (s, 3H), 3.15-3.20 (m, 1H), 3.70-3.82 (m, 2H), 4.00 (m, 2H), 4.15(m, 1H), 4.40 (m, 1H), 4.80 (m, 1H), 5.10 (d, 1H), 5.45 (d, 1H), 5.62(d, 1H), 5.70 (d, 1H), 6.38 (d, 1H), 6.50-7.50 (m, 14H);

¹⁹F-NMR(DMSO-d₆) δ:

−58.45

HRMS (ESI) As C₃₁H₃₀CN₂O₃F₃RuS.

Calculated value: [M+H]⁺ 705.7034.

Found value: 705.0758.

Example 44 Asymmetrichydrogen Transfer Reaction of Acetophenone UsingComplex RuCl((R,R)—O-HT-o-TFTsdpen) (S/C=1000)

In a 50-ml Schlenk tube, 3.5 mg (0.005 mmol) of the complexRuCl((R,R)—O-HT-o-TFTsdpen) produced in Example 43 as described above,0.58 ml (0.60 g, 5 mmol) of acetophenone, and 2.5 ml of a formicacid-triethylamine (5:2) azeotropic mixture were mixed, and the Schlenktube was purged with nitrogen. Subsequently, the mixture was allowed toreact for 5 hours at 60° C. An analysis of the reaction liquid wascarried out by GC, and it was found that (R)-1-phenylethanol with 97.5%ee was produced at a conversion rate of 98.9%.

Example 45 Production of2,4,6-triisopropyl-N-((1S,2S)-2-(2-((4-methylcyclohexa-1,4-dienyl)methoxy)ethylamino)-1,2-diphenylethyl)benzenesulfonamide

6.03 g (18.82 mmol) of the tosylate obtained in Example 37 as describedabove was dissolved in 25 ml of toluene, and 2.43 g (18.82 mmol) ofDIPEA and 9.00 g (18.80 mmol) of (S,S)-TIPPsDPEN were added to thesolution. The mixture was stirred for 13 hours at 135° C. Subsequently,the solvent was distilled off under reduced pressure, and the residuethus obtained was purified by silica gel column chromatography(toluene/ethyl acetate=20/1→15/1). Thus, 10.53 g of the title compoundwas obtained as a colorless oil. Yield 89.0%.

¹H-NMR(CDCl₃, 300 MHz) δ:

1.06 (d, J=6.9 Hz, 3H), 1.21 (d, J=6.9 Hz, 3H), 1.87 (brs, 1H), 1.68 (s,3H), 2.60 (brs, 4H), 2.71-2.48 (m, 2H), 3.52-3.34 (m, 2H), 3.55 (d,J=8.9 Hz, 1H), 3.77 (s, 2H), 3.95 (septet, J=6.7 Hz, 3H), 4.40 (d, J=8.9Hz, 1H), 5.44 (m, 1H), 5.64 (m, 1H), 6.52 (brs, 1H), 6.74-7.28 (m, 12H);

HRMS (ESI):

As C₃₉H₅₃N₂O₃S.

Calculated value: [M+H]⁺ 629.3771.

Found value: 629.3771.

Example 46 Production of RuCl((S,S)—O-HT-TIPPsdpen)

2.02 g (3.21 mmol) of the sulfonamide obtained in Example 45 asdescribed above was dissolved in 8 ml of methanol. Under ice cooling,0.67 g (6.42 mmol) of a 1 M methanol solution of hydrochloric acid wasadded to the solution, and the mixture was stirred for 20 minutes atroom temperature. Subsequently, the solvent was distilled off underreduced pressure, and the residue thus obtained was dissolved in 30 mlof 3-methoxypropanol and 18 ml of water. 0.72 g (2.75 mmol) of rutheniumtrichloride trihydrate was added to the solution, and the mixture wasstirred for one hour at 120° C. The solvent was distilled off underreduced pressure, and to the residue thus obtained, 35 ml of IPA and0.72 g (7.15 mmol) of triethylamine were added. The resulting mixturewas stirred for one hour at 60° C. The solvent was distilled off underreduced pressure, and the residue thus obtained was purified by silicagel column chromatography (chloroform/methanol=97/3→20/1). Thus, 1.28 gof the desired Ru complex was obtained. Yield 52.3%.

¹H-NMR(CD₂Cl₂ 500 MHz) δ:

1.0-1.2 (m, 18H), 1.70 (m, 1H), 2.41 (s, 3H), 2.60 (m, 1H), 3.05 (m,1H), 3.35 (m, 1H), 3.68 (m, 1H), 3.75 (t, 1H), 3.85 (m, 2H), 4.18 (d,1H), 4.25 (d, 1H), 4.85 (brs, 1H), 5.02 (d, 1H), 5.30 (d, 1H), 5.48 (d,1H), 5.63 (d, 1H), 6.35 (d, 1H), 6.40-6.70 (m, 10H), 6.90-7.05 (m, 3H);

HRMS (ESI):

As C₃₉H₅₀N₂O₃SClRu.

Calculated value: [M+H]⁺ 763.2269.

Found value: 763.2257.

Example 47 Asymmetric Hydrogen Transfer Reaction of Acetophenone UsingComplex RuCl((S,S)—O-HT-TIPPsdpen) (S/C=1000)

In a 50-ml Schlenk tube, 2.8 mg (0.005 mmol) of the complexRuCl(S,S)—O-HT-TIPPsDPEN) produced in Example 46 as described above,0.58 ml (0.60 g, 5 mmol) of acetophenone, and 2.5 ml of a formicacid-triethylamine (5:2) azeotropic mixture were mixed, and the Schlenktube was purged with nitrogen. Subsequently, the mixture was allowed toreact for 10 hours at 60° C. An analysis of the reaction liquid wascarried out by GC, and it was found that (S)-1-phenylethanol with 95.8%ee was produced at a conversion rate of 38.5%.

Example 48 Production of 4-(4,5-dimethylcyclohexa-1,4-dienyl)butan-1-ol

800 mg (2.00 mmol) of 1,2-bis(diphenylphosphino)ethane, 437 mg (2.00mmol) of cobalt bromide, 1.28 g (4.00 mmol) of zinc iodide, and 260 mg(4.00 mmol) of zinc were added to 40 ml of THF, and the solution wasstirred for 15 minutes at 70° C. The solution was cooled to roomtemperature, and 9.86 g (120 mmol) of 2,3-dimethyl-1,3-butadiene wasadded thereto. Subsequently, 9.8 g (100 mmol) of 5-hexyn-1-ol was slowlyadded dropwise to the mixture in a water bath. The resulting mixture wasstirred for one hour at 35° C., and then the solvent was distilled offunder reduced pressure. The residue thus obtained was purified by silicagel column chromatography (hexane/ethyl acetate=3/1), and thus 11.5 g ofthe title compound alcohol was obtained as a colorless oil. Yield 63.4%.

¹H-NMR(CDCl₃, 300 MHz) δ:

1.28 (bs, 1H), 1.79-1.46 (m, 4H), 1.63 (s, 6H), 1.98-2.11 (m, 3H),2.48-2.61 (m, 2H), 3.63-3.67 (m, 2H), 5.41-5.56 (m, 1H);

Example 49 Production of 4-(4,5-dimethylcyclohexa-1,4-dienyl)butyl4-methylbenzenesulfonate

11.0 g (61.0 mmol) of 4-(4,5-dimethylcyclo-1,4-diene)butan-1-ol, 7.40 g(73.08 mmol) of triethylamine, and 6.0 g (73.0 mmol) of1-methylimidazole were dissolved in 55 ml of toluene. In an ice bath, 40ml of a toluene solution of 13.9 g (73.1 mmol) of p-toluenesulfonylchloride was slowly added dropwise to the solution, and then theresulting mixture was stirred for one hour at room temperature. Waterwas added to the mixture, and the organic layer was separated. Theobtained organic layer was washed with 2 M hydrochloric acid and water.The solvent was distilled off under reduced pressure, and the residuethus obtained was purified by silica gel column chromatography(hexane/ethyl acetate=20/1→4/1). Thus, 16.3 g of tosylate of the titlecompound was obtained. Yield 80%.

¹H-NMR(CDCl₃, 300 MHz) δ:

1.60-1.41 (m, 2H), 1.67 (s, 6H), 1.79-1.74 (m, 3H), 1.89-2.05 (m, 3H),2.45 (s, 3H), 2.53 (brs, 2H), 4.00-4.05 (m, 2H), 5.28-5.40 (m, 1H),7.33-7.36 (d, 2H), 7.77-7.80 (d, 2H);

Example 50 Production ofN-((1R,2R)-2-(2-((4,5-dimethylcyclohexa-1,4-dienyl)methoxy)ethylamino)-1,2-diphenylethyl)methanesulfonamide

8.00 g (23.78 mmol) of the tosylate obtained in Example 49 was dissolvedin 35 ml of toluene, and 3.07 g (23.78 mmol) of DIPEA and 6.90 g (23.78mmol) of (R,R)-MsDPEN were added to the solution. The mixture wasstirred for 12.5 hours at 135° C. Subsequently, the solvent wasdistilled off under reduced pressure, and the residue thus obtained waspurified by silica gel column chromatography (hexane/ethyl acetate=2/1).Thus, 9.83 g of the title compound was obtained as a colorless solid.Yield 90.9%.

¹H-NMR(CDCl₃, 300 MHz) δ:

1.65 (s, 3H), 1.68 (s, 3H), 1.89-1.75 (m, 1H), 2.33 (s, 3H), 2.46-2.54(m, 3H), 2.60-2.71 (m, 3H), 3.35-3.48 (m, 2H), 3.77 (s, 2H), 3.81 (d,J=7.8 Hz, 1H), 4.47 (d, J=7.8 Hz, 1H), 5.60 (m, 1H), 6.21 (brs, 1H),7.10-7.27 (m, 10H);

HRMS (ESI):

As C₂₆H₃₅N₂O₃S.

Calculated value: [M+H]⁺ 455.2363.

Found value: 455.2358.

Example 51 Production of RuCl(R,R)-xyl-O-HT-Msdpen)

2.00 g (4.40 mmol) of the diamine compound obtained in Example 50 wasdissolved in 8 ml of dichloromethane. Under ice cooling, 0.92 g (8.80mmol) of a 1 M methanol solution of hydrochloric acid was added to thesolution, and the mixture was stirred for 20 minutes at roomtemperature. Subsequently, the solvent was distilled off under reducedpressure, and the residue thus obtained was dissolved in 30 ml of3-methoxypropanol and 18 ml of water. 0.97 g (3.71 mmol) of rutheniumtrichloride trihydrate was added to the solution, and the resultingmixture was stirred for one hour at 120° C. The solvent was distilledoff under reduced pressure, and to the residue thus obtained, 35 ml ofIPA and 0.80 g (7.87 mmol) of triethylamine were added. The resultingmixture was stirred for one hour at 60° C. The solvent was distilled offunder reduced pressure, and the residue thus obtained was purified bysilica gel column chromatography (chloroform/methanol=97/3→20/1). Thus,1.48 g of the desired Ru complex was obtained. Yield 57.2%.

¹H-NMR(CDCl₃, 300 MHz) δ:

2.27 (s, 3H), 2.30 (s, 3H), 2.39 (s, 3H), 3.15-3.35 (m, 2H), 3.75-3.85(m, 2H), 4.00-4.10 (m, 2H), 3.95-4.05 (brs, 1H), 4.42 (d, 1H), 4.85 (d,1H), 5.50 (d, 1H), 5.76 (s, 1H), 5.85 (d, 1H), 6.82-7.22 (m, 10H);

HRMS (ESI):

As C₂₆H₃₂N₂O₃SClRu.

Calculated value: [M+H]⁺ 589.0860.

Found value: 589.0863.

Example 52 Asymmetric Hydrogen Transfer Reaction of Acetophenone UsingComplex RuCl(R,R)-xyl-O-HT-Msdpen) (S/C=1000)

In a 50-ml Schlenk tube, 2.8 mg (0.005 mmol) of the complexRuCl((R,R)-xyl-O-HT-Msdpen) produced in Example 51 as described above,0.58 ml (0.60 g, 5 mmol) of acetophenone, and 2.5 ml of a formicacid-triethylamine (5:2) azeotropic mixture were mixed, and the Schlenktube was purged with nitrogen. Subsequently, the mixture was reacted for10 hours at 60° C. An analysis of the reaction liquid was carried out byGC, and it was found that (R)-1-phenylethanol with 95.9% ee was producedat a conversion rate of 95.4%.

Example 53 Production of4-methyl-N-((1R,2R)-2-(2-((4-methylcyclohexa-1,4-dienyl)methoxy)ethylamino)cyclohexyl)benzenesulfonamidehydrochloride

5.06 g (16.4 mmol) of the tosylate obtained in Example 37 was dissolvedin 26 ml of toluene, and 2.12 g (16.4 mmol) of DIPEA, 4.00 g (14.9 mmol)of (R,R)-TsCYDN, and 2.72 g (16.4 mmol) of potassium iodide were addedto the solution. The resulting mixture was stirred for 20 hours at 135°C. The reaction liquid was concentrated and purified by silica gelcolumn chromatography. Thereby, 2.92 g of diamine L was obtained. Yield46.9%. Subsequently, 42 ml of dichloromethane and 24.6 ml of anHCl-methanol solution (1 N) were added to 2.8 g (6.69 mmol) of thediamine L, and the resulting mixture was stirred for 0.5 hours.Subsequently, the solvent was removed, and thus 2.9 g of the desireddiamine hydrochloride M was obtained. Yield 94.7%.

¹H-NMR(DMSO-d₆, 300 MHz) δ:

0.95-1.30 (m, 4H), 1.50 (m, 2H), 1.63 (s, 3H), 2.10 (m, 2H), 2.40 (s,3H), 2.60 (m, 2H), 2.95 (brd, 1H), 3.18 (m, 2H), 3.60 (m, 2H), 3.90 (s,2H), 5.40 (m, 1H), 5.70 (m, 1H), 7.40 (d, 1H), 7.75 (d, 1H), 8.15 (d,1H), 8.23 (brd, 1H), 9.10 (brd, 1H)

HRMS (ESI):

As C₂₃H₃₄N₂O₃S.

Calculated value: [M−Cl]⁺ 419.2363.

Found value: 419.2365.

Example 54 Production of RuCl(R,R)—O-HT-Tscydn)

0.5 g (1.1 mmol) of the diamine hydrochloride produced in Example 53 wasdissolved in 15 ml of 3-methoxypropanol and 3 ml of water. 0.25 g (0.96mmol) of ruthenium trichloride trihydrate and 0.08 g (0.96 mmol) ofsodium hydrogen carbonate were added to the solution, and the resultingmixture was stirred for one hour at 120° C. 12 ml of 3-methoxypropanolwas recovered, and then 13 ml of MIBK and 0.39 g (3.82 mmol) oftriethylamine were added to the residue. The resulting mixture wasstirred for one hour at 60° C. 0.3 M hydrochloric acid was addedthereto, and the organic layer was separated. The obtained organic layerwas washed two times with water. After washing, approximately 10 ml ofthe solvent was recovered, 15 ml of heptane was added to the residue,and the resulting mixture was subjected to crystallization. Crystalsprecipitated therefrom were collected by filtration, and thus 0.24 g ofthe desired Ru complex was obtained. Yield 45.5%.

¹H-NMR(CD₂Cl, 500 MHz) δ:

0.65-1.05 (m, 4H), 1.90 (m, 1H), 1.15 (m, 1H), 2.08 (m, 1H), 2.70 (m,1H), 2.75 (s, 1H), 2.77 (s, 1H), 2.60 (m, 1H), 3.60-3.70 (m, 2H), 3.80(m, 1H), 4.00 (m, 1H), 4.25 (m, 1H), 4.35 (d, 1H), 4.92 (d, 1H), 5.25(d, 1H), 5.50 (d, 1H), 5.67 (d, 1H), 5.83 (d, 1H), 7.20 (d, 1H), 7.80(d, 1H);

HRMS (ESI):

As C₂₃H₃₁N₂O₃RuS.

Calculated value: [M−Cl]⁺ 517.1093.

Found value: 517.1101.

Example 55 Asymmetric Hydrogen Transfer Reaction of Acetophenone UsingComplex RuCl(R,R)—O-HT-Tscydn) (S/C=1000)

In a 50-ml Schlenk tube, 2.8 mg (0.005 mmol) of the complexRuCl(R,R)—O-HT-Tscydn) produced in Example 54 as described above, 0.58ml (0.60 g, 5 mmol) of acetophenone, and 2.5 ml of a formicacid-triethylamine (5:2) azeotropic mixture were mixed, and the Schlenktube was purged with nitrogen. Subsequently, the mixture was allowed toreact for 10 hours at 60° C. An analysis of the reaction liquid wascarried out by GC, and it was found that (R)-1-phenylethanol with 95.5%ee was produced at a conversion rate of 73.7%.

Example 56 Production of2,4,6-trimethyl-N-((1R,2R)-2-(2-(4-methylcyclohexa-1,4-dienyl)methoxy)ethylamino)-1,2-diphenylethyl)benzenesulfonamide

1.0 g (3.0 mmol) of the tosylate obtained in Example 37 was dissolved in5 ml of toluene, and 0.39 g (3.0 mmol) of DIPEA and 1.3 g (3.3 mmol) of(R,R)-MESsDPEN were added to the solution. The mixture was stirred for 8hours at 120° C. Subsequently, the solvent was distilled off underreduced pressure, and the residue thus obtained was purified by silicagel column chromatography (toluene/ethyl acetate=4/1). Thus, 0.71 g ofthe title compound was obtained as a colorless oil. Yield 44.7%.

Example 57 Production of RuCl(R,R)—O-HT-MESsDPEN)

0.67 g (1.2 mmol) of the sulfonamide obtained in Example 56 wasdissolved in 5 ml of methanol. Under ice cooling, 0.25 g (2.4 mmol) of a1 M methanol solution of hydrochloric acid was added to the solution,and the resulting mixture was stirred for 20 minutes at roomtemperature. Subsequently, the solvent was distilled off under reducedpressure, and the residue thus obtained was dissolved in 20 ml of2-methoxyethanol, 2 ml of water, and 0.09 g (1.2 mmol) of sodiumhydrogen carbonate. 0.36 g (1.35 mmol) of ruthenium trichloridetrihydrate was added to the solution, and the resulting mixture wasstirred for 3 hours at 120° C. The solvent was distilled off underreduced pressure, and to the residue thus obtained, 40 ml of ethanol and0.5 g (4.94 mmol) of triethylamine were added. The resulting mixture wasstirred for 2 hours at 80° C. The solvent was distilled off underreduced pressure, and the residue thus obtained was purified by silicagel column chromatography (chloroform/methanol=20/1). Thus, 0.13 g ofthe desired Ru complex was obtained. Yield 16.0%.

¹H-NMR(CD₂Cl, 500 MHz) δ:

1.95 (s, 3H), 2.45 (s, 6H), 2.46 (s, 3H), 3.05 (m, 1H), 3.70 (m, 1H),3.80 (d, 1H), 3.85 (m, 2H), 3.95 (d, 1H), 4.25 (d, 1H), 4.75 (m, 1H),5.00 (d, 1H), 5.40 (d, 1H), 5.50 (d, 1H), 5.60 (d, 1H), 6.30 (s, 2H),6.53 (d, 1H), 6.40-7.00 (m, 10H);

HRMS (ESI):

As C₃₃H₃₇ClN₂O₃RuS.

Calculated value: [M+H]⁺ 679.1335.

Found value: 679.1327.

Example 58 Production of Ru((R,R)—O-HT-TsDPEN)

To a suspension of RuCl(R,R)—O-HT-TsDPEN) 140 mg (0.215 mmol) andpotassium hydroxide 84 mg (1.28 mmol) in dichloromethane (10 mL) wasadded water (1 mL). The reaction mixture was stirred at room temperaturefor 20 min. Then the organic solution was washed with water three times(10 mL×3). The organic layer was concentrated under reduced pressure togive the desired product as purple solid. Yield 125 mg (95%)

¹H NMR (500 MHz, CD₂Cl₂) δ 7.48 (d, J=7.3 Hz, 2H), 7.40 (d, J=8.0 Hz,2H), 7.30-6.85 (m, 8H), 6.98 (d, J=8.0 Hz, 2H), 6.15 (d, J=6.3 Hz, 1H),5.55 (d, J=6.0 Hz, 1H), 5.45 (dd, J=6.3, 6.0 Hz, 2H), 4.95 (d, J=14.4Hz, 1H), 4.35 (d, J=14.4 Hz, 1H), 4.13 (s, 1H), 3.55-3.42 (m, 2H),3.36-3.28 (m, 1H), 3.35 (s, 1H), 3.08-3.00 (m, 1H), 2.60 (s, 3H), 2.32(s, 3H);

HRMS (ESI):

As C₃₁H₃₃N₂O₃S.

Calculated value: [M+H]⁺ 615.1250.

Found value: 615.1231.

Example 59 Production of RuH((R,R)—O-HT-TsDPEN)

To a suspension of RuCl(R,R)—O-HT-TsDPEN) 140 mg (0.215 mmol) andpotassium hydroxide 84 mg (1.28 mmol) in dichloromethane (10 mL) wasadded water (1 mL). The reaction mixture was stirred at room temperaturefor 20 min. Then the organic solution was washed with water three times(10 mL×3). The organic layer was separated to another Schlenk tube andthis solution was added formic acid (2 mL). The reaction mixture wasstirred at room temperature for 5 min. Then the organic solution waswashed with water three times (10 mL×3). The organic layer wasconcentrated under reduced pressure to give the desired product as lightbrown solid. Yield 120 mg (90%)

¹H NMR (300 MHz, CD₂Cl₂) 67 7.50-6.60 (m, 14H), 6.30 (d, J=4.5 Hz, 1H),6.05 (m, 2H), 5.45 (m, 1H), 4.85 (d, J=13.5 Hz, 1H), 4.78 (d, J=4.5 Hz,1H), 4.25-3.90 (m, 4H), 3.85 (d, J=13.5 Hz, 1H), 3.20-3.15 (m, 1H),2.80-2.70 (m, 1H), 2.22 (s, 3H), 2.20 (s, 1H), −5.10 (s, 1H);

HRMS (ESI):

As C₃₁H₃₃N₂O₃S Calculated value: [M−H]⁺ 615.1250.

Found value: 615.1243.

Example 60 Production of Ru (BF₄)((R,R)—O-HT-TsDPEN)

To a suspension of RuCl(R,R)—O-HT-TsDPEN) 140 mg (0.215 mmol) andpotassium hydroxide 84 mg (1.28 mmol) in dichloromethane (10 mL) wasadded water (1 mL). The reaction mixture was stirred at room temperaturefor 20 min. Then the organic solution was washed with water three times(10 mL×3). The organic layer was separated to another Schlenk tube andthis solution was added 42% aqueous HBF₄ solution (0.5 mL). The reactionmixture was stirred at room temperature for 5 min. Then the organicsolution was washed with water three times (10 mL×3). The organic layerwas concentrated under reduced pressure to give the desired product asbrown solid. Yield 136 mg (90%)

¹H-NMR(CD₃OD, 300 MHz) δ:

2.12 (s, 3H), 2.46 (s, 3H), 3.35-3.60 (m, 4H), 3.60-3.80 (m, 1H),3.95-4.10 (m, 3H), 4.70-4.80 (m, 1H), 5.84 (d, 1H), 5.89 (d, 1H), 5.99(d, 1H), 6.20 (d, 1H), 6.46-7.50 (m, 14H)

HRMS (ESI):

As C₃₁H₃₃BF₄N₂O₃RuS.

Calculated value: [M−BF₄]⁺ 615.1250.

Found value: 615.1271.

INDUSTRIAL APPLICABILITY

The present invention provides a novel ruthenium complex which can beproduced conveniently and safely. The ruthenium complex of the presentinvention is a ruthenium complex which has a very strong catalyticactivity, is useful as a catalyst for various hydrogenation reactions,is also useful as a catalyst for asymmetric reduction having excellentstereoselectivity and capable of giving a high enantiomeric excess, andis useful in the field of industrial chemistry.

The invention claimed is:
 1. A ruthenium complex represented by thefollowing formula (1):

wherein symbol * represents an asymmetric carbon atom; R¹ represents analkyl group having 1 to 10 carbon atoms; a halogenated alkyl grouphaving 1 to 10 carbon atoms; 10-camphoryl group; an amino group which isoptionally substituted with one or two alkyl group having 1 to 10 carbonatoms; an aryl group which is optionally substituted with an alkyl grouphaving 1 to 10 carbon atoms, a halogenated alkyl group having 1 to 10carbon atoms, a halogen atom, a cyano group (—CN), an amino group, analkylated amino group (—NR²⁰R²¹), a five or six membered cyclic aminogroup, an acylated amino group (—NH—CO—R²⁰), a hydroxyl group, an alkoxygroup (—OR²⁰), an acyl group (—CO—R²⁰), a carboxyl group, analkoxycarbonyl group (—COOR²⁰), a phenoxy carbonyl group, a mercaptogroup, an alkylthio group (—SR²⁰), a silyl group (—SiR²⁰R²¹R²²), or anitro group (—NO₂); R²⁰, R²¹ and R²² each independently represent ahydrogen atom, an alkyl group having 1 to 10 carbon atoms or acycloalkyl group having 3 to 10 carbon atoms; Y represents a hydrogenatom; X represents a trifluoromethanesulfonyloxy group, ap-toluenesulfonyloxy group, a methanesulfonyloxy group, abenzenesulfonyloxy group, a hydrogen atom, or a halogen atom; j and keach represent 0 or 1, but j+k is not 1; R² and R³ each independentlyrepresent a hydrogen atom; an alkyl group having 1 to 10 carbon atoms; aphenyl group which is optionally substituted with an alkyl group having1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms, or ahalogen atom; or a cycloalkyl group having 3 to 8 carbon atoms, or R²and R³ is optionally joined together to form a ring; R¹¹, R¹², R¹³, R¹⁴and R¹⁵ each independently represent a hydrogen atom, an alkyl grouphaving 1 to 10 carbon atoms, or an alkoxy group having 1 to 10 carbonatoms; R¹⁶ and R¹⁷ each independently represent a hydrogen atom, ahydroxyl group, an alkyl group having 1 to 10 carbon atoms, or an alkoxygroup having 1 to 10 carbon atoms, or one R¹⁶ and one R¹⁷ with thecarbon atom which is substituted with said one R¹⁶ and one R¹⁷ form acarbonyl group; R¹⁸ and R¹⁹ each independently represent a hydrogenatom, a hydroxyl group, an alkyl group having 1 to 10 carbon atoms, oran alkoxy group having 1 to 10 carbon atoms, or one R¹⁸ and one R¹⁹ withthe carbon atom which is substituted with said one R¹⁸ and one R¹⁹ forma carbonyl group; Z represents an oxygen atom or a sulfur atom; and n₁represents 1 or 2, and n₂ represents 1, 2 or
 3. 2. A method forproducing a reduction product by reducing an organic compound in thepresence of the ruthenium complex as set forth in claim 1 and a hydrogendonor.
 3. The method according to claim 2, wherein the hydrogen donor isselected from formic acid, a formic acid alkali metal salt, and analcohol having a hydrogen atom on the α-position carbon atom substitutedwith a hydroxyl group.
 4. The method according to claim 2, wherein thehydrogen donor is hydrogen.
 5. A method for producing an opticallyactive alcohol, the method comprising reducing a carbonyl group of acarbonyl compound in the presence of the ruthenium complex according toclaim 1 and a hydrogen donor.
 6. A method for producing an opticallyactive amine, the method comprising reducing an imino group of an iminecompound in the presence of the ruthenium complex according to claim 1and a hydrogen donor.
 7. A catalyst for reduction, comprising theruthenium complex according to claim
 1. 8. The catalyst according toclaim 7, wherein the catalyst is a catalyst for asymmetric reduction. 9.A ruthenium complex represented by the following formula (2):

wherein symbol * represents an asymmetric carbon atom; R¹ represents analkyl group having 1 to 10 carbon atoms; a halogenated alkyl grouphaving 1 to 10 carbon atoms; 10-camphoryl group; an amino group which isoptionally substituted with one or two alkyl group having 1 to 10 carbonatoms; an aryl group which is optionally substituted with an alkyl grouphaving 1 to 10 carbon atoms, a halogenated alkyl group having 1 to 10carbon atoms, a halogen atom, a cyano group (—CN), an amino group, analkylated amino group (—NR²⁰R²¹), a five or six membered cyclic aminogroup, an acylated amino group (—NH—CO—R²⁰), a hydroxyl group, an alkoxygroup (—OR²³), an acyl group (—CO—R²⁰), a carboxyl group, analkoxycarbonyl group (—COOR²⁰), a phenoxy carbonyl group, a mercaptogroup, an alkylthio group (—SR²⁰), a silyl group (—SiR²⁰R²¹R²²), or anitro group (—NO₂); R²⁰, R²¹ and R²² each independently represent ahydrogen atom, an alkyl group having 1 to 10 carbon atoms or acycloalkyl group having 3 to 10 carbon atoms; Y represents a hydrogenatom; R² and R³ each independently represent a hydrogen atom; an alkylgroup having 1 to 10 carbon atoms; a phenyl group which is optionallysubstituted with an alkyl group having 1 to 10 carbon atoms, an alkoxygroup having 1 to 10 carbon atoms, or a halogen atom; or a cycloalkylgroup having 3 to 8 carbon atoms, or R² and R³ is optionally joinedtogether to form a ring; R¹¹, R¹², R¹³, R¹⁴ and R¹⁵ each independentlyrepresent a hydrogen atom, an alkyl group having 1 to 10 carbon atoms,or an alkoxy group having 1 to 10 carbon atoms; R¹⁶ and R¹⁷ eachindependently represent a hydrogen atom, a hydroxyl group, an alkylgroup having 1 to 10 carbon atoms, or an alkoxy group having 1 to 10carbon atoms, or one R¹⁶ and one R¹⁷ with the carbon atom which issubstituted with said one R¹⁶ and one R¹⁷ form a carbonyl group; R¹⁸ andR¹⁹ each independently represent a hydrogen atom, a hydroxyl group, analkyl group having 1 to 10 carbon atoms, or an alkoxy group having 1 to10 carbon atoms, or one R¹⁸ and one R¹⁹ with the carbon atom which issubstituted with said one R¹⁸ and one R¹⁹ form a carbonyl group; Zrepresents an oxygen atom or a sulfur atom; Q⁻ represents a counteranion; and n₁ represents 1 or 2, and n₂ represents 1, 2 or
 3. 10. Amethod for producing a reduction product by reducing an organic compoundin the presence of the ruthenium complex as set forth in claim 9 and ahydrogen donor.
 11. The method according to claim 10, wherein thehydrogen donor is selected from formic acid, a formic acid alkali metalsalt, and an alcohol having a hydrogen atom on the α-position carbonatom substituted with a hydroxyl group.
 12. The method according toclaim 10, wherein the hydrogen donor is hydrogen.
 13. A method forproducing an optically active alcohol, the method comprising reducing acarbonyl group of a carbonyl compound in the presence of the rutheniumcomplex according to claim 9 and a hydrogen donor.
 14. A method forproducing an optically active amine, the method comprising reducing animino group of an imine compound in the presence of the rutheniumcomplex according to claim 9 and a hydrogen donor.
 15. A catalyst forreduction, comprising the ruthenium complex according to claim
 9. 16.The catalyst according to claim 15, wherein the catalyst is a catalystfor asymmetric reduction.